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ABSTRACT: The barrier to rotation around the N-alkenyl bond of 38 N-alkenyl-N-alkylacetamide derivatives was measured
(ΔG⧧ rotation varied between <8.0 and 31.0 kcal mol−1). The most important factor in controlling the rate of rotation was the
level of alkene substitution, followed by the size of the nitrogen substituent and, finally, the size of the acyl substituent. Tertiary
enamides with four alkenyl substituents exhibited half-lives for rotation between 5.5 days and 99 years at 298 K, sufficient to
isolate enantiomerically enriched atropisomers. The radical cyclizations of a subset of N-alkenyl-N-benzyl-α-haloacetamides
exhibiting relatively high barriers to rotation round the N-alkenyl bond (ΔG⧧ rotation >20 kcal mol−1) were studied to determine
the regiochemistry of cyclization. Those with high barriers (>27 kcal mol−1) did not lead to cyclization, but those with lower
values produced highly functionalized γ-lactams via a 5-endo-trig radical−polar crossover process that was terminated by
reduction, an unusual cyclopropanation sequence, or trapping with H2O, depending upon the reaction conditions. Because
elevated temperatures were necessary for cyclization, this precluded study of the asymmetric transfer in the reaction of individual
atropisomers. However, enantiomerically enriched atropsiomeric enamides should be regarded as potential asymmetric building
blocks for reactions that can be accomplished at room temperature.
■ INTRODUCTION
In recent years, the bond rotational dynamics, asymmetric
synthesis, and reactions of nonbiaryl atropisomers have
received considerable attention.1−3 The majority of work has
focused on the chemistry of anilides 1a4−9 and benzamides
1b,10−14 where the amide group is perpendicular to the plane of
the aryl system (Figure 1). In 2,6-disubstituted anilide
derivatives 1a (R3 or R4 ≠ H) rotation around the N-aryl
bond is slow enough for atropisomers to be separated at room
temperature, and axially chiral anilides 1a have been shown to
undergo a range of reactions with transfer of chirality.3
Secondary enamides are valuable synthetic intermediates,15,16
but the chemistry of tertiary enamides 1c has received much
less attention.17,18 Systems with small substituents 2 (e.g., R1 =
R2 = Me) may be planar in the ground state, but if substituents
R1 and R2 are large enough or the alkene is substituted (R3 = R4
= R5 ≠ H), then enamides 1c have the potential to exhibit axial
chirality. Theoretically, if the rotation barrier around the N-
alkenyl bond is high enough, then individual atropisomers may
be separated and their chemistry studied.
The rotation dynamics of tertiary enamides can be
complicated because of restricted rotation around both the
amide N−CO [(E)-syn 2 → (Z)-syn 2] and the N-alkenyl
bonds [(E)-syn 2 → (E)-anti 2] (Figure 1). The barrier to
rotation around the amide N−CO bond for 2a (R1 = R2 = Me)
has been measured at 14.0 kcal mol−1 and is slightly lower19
than the general value for amides (15−20 kcal mol−1).20 N-
Cycloalkenyl-N-alkylacetamides such a 3 generally prefer the
amide N−CO E-rotamer21 and exhibit transient axial chirality
on the NMR time scale. This makes analysis of the rotational
dynamics around the N-alkenyl bond relatively easy to study by
VT 1H NMR.21 In this paper we report studies into the effect of
substitution (1c, R1, R2, R3, R4, and R5) on the barriers to
rotation around the N-alkenyl bond of tertiary enamides and
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show that it is possible to separate individual enamide
atropisomers at room temperature with half-lives (t1/2) of up
to 99 years at 298 K. We probe the ability of a subset of
sterically congested racemic α-halogenated tertiary enamides
with relatively high barriers to rotation (ΔG‡298 rot > 20 kcal
mol−1) to undergo 5-endo-trig radical cyclization. Those with
high barriers (ΔG⧧298 rot > 27 kcal mol−1) do not lead to
cyclization, but those with lower values (27 kcal mol−1 >
ΔG⧧298 rot > 20 kcal mol−1) mostly lead to highly functionalized
γ-lactams (no β-lactam formation was observed), where the
mode of termination is controlled in part by steric factors and
in part by the method of cyclization.
■ RESULTS AND DISCUSSION
Substitution at the Alkene. Compound 2b (R1 = Me, R2
= Bn) was prepared by acetylation of the N-benzylimine of
acetaldehyde22 (13%). Computational analysis of 2b using the
TZVP basis set23 and the B3LYP-D3(BJ) functional24 using
PC-GAMESS/Firefly 8.025 suggested that three out of the four
possible conformations were planar [the exception being (E)-
syn-2b] with (E)-anti-2b and (Z)-anti-2b conformations
predominating at equilibrium (Figure 2). Electronic energies
and zero-point energies for all conformations are provided in
the Supporting Information. Two diastereomeric versions of
the nonplanar (E)-syn-2b conformation exist, where either the
vinyl group or the phenyl group are angled either in front of the
plane of the amide or behind it. The energy and relative
equilibrium constant of the more stable conformer are shown.
In all cases the minimized energy structures had imaginary
frequencies of zero. The E+ZPE energy was used to calculate
the relative populations at 298 K.
Experimentally, a 2:1 ratio of two conformations was
observed in the 600 MHz 1H NMR spectrum of 2b in
CDCl3 at 298 K. The major isomer was confirmed as (E)-anti-
2b and the minor isomer (Z)-anti-2b upon the basis of their
calculated theoretical 1H NMR chemical shifts and NOE data.
DFT ground-state structures were analyzed using the GIAO
method Gaussian03,26 with the mPW1PW91 functional27 and
the 6-311+G(2d,p) basis set and scrf = (solvent =
chcl3,cpcm,read) radii = uaks nosymcav options.28 NMR shifts
were calculated using parameters specific to the functional,
basis set, and option combination described Lodewyk et al.29
The H-1 enamide proton resonates at 6.80 ppm in the major
conformer and 7.50 ppm in the minor conformer, in good
agreement with the theoretical calculations. This data is similar
to that reported for the related N-benzyl-N-vinylformamide 2c
(R1 = H, R2 = Bn)30 and is consistent with a slow rotation
around the amide bond and a fast rotation around the C−N
bond of the alkene with a higher population of the (E)-anti
conformer at equilibrium at room temperature. Heating 2b
(298 K → 373 K) in toluene-d8 caused a broadening of all
signals and coalescence to a single set of peaks, consistent with
rapid rotation around the amide bond.
In order to assess the effect of increasing alkene substitution
on the barrier to N-alkenyl bond rotation, we prepared
structures 4a−i (Figure 3). We chose to study the N-benzyl
derivatives, as measurement of rotation rates should be possible
using variable-temperature (VT) 1H NMR. Upon cooling, the
benzylic CH2 singlet should broaden and would be expected to
decoalesce (caused by the two protons of the CH2 group being
Figure 1. Structures of some axially chiral molecules and
conformations of tertiary enamides 2.
Figure 2. Calculated relative energies, 1H NMR shifts, and equilibrium
contributions of conformers of 2b.
Figure 3. Effect of alkenyl substitution on the barrier for rotation
around the N-alkenyl bond of 4a−i (ΔG⧧298 in kcal mol−1 for rotation
around the N-alkenyl bond is shown in parentheses).
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in an asymmetric environment) and ultimately form two
doublets due to the diastereotopic nature of the benzylic
protons. This behavior is not consistent with amide bond
rotation, as this would cause the number of signals to double.
Using the WINDNMR 7.1 line shape analysis program,31 it was
possible to determine the rotational rate constant at each
temperature and the thermodynamic parameters via a standard
Eyring plot. Compounds 4a,32 4e, and 4f were prepared by
acetylation of the known benzyl imines of acetone,22 2-methyl
propanal,22 and 2-phenylcyclohexanone,33 while 4b−d and 4g−
i were prepared by benzylation (NaH, BnBr) or methylation
(NaH, MeI) of the corresponding N-acetyl enamides 5 (16−
80%).34−37 The barrier to rotation around the C−N bond for
4a and 4e was too low to measure by VT 1H NMR (ΔG⧧298
estimated to be <8.5 kcal mol−1). On cooling, the benzylic CH2
singlet began to broaden as expected, but even at 179 K
decoalescence was not observed. On the other hand, the values
of ΔG⧧298 for rotation for the 1,2-substituted derivatives 4b−d
in toluene-d8 were determined to be 16.3, 18.6, and 9.3 kcal
mol−1. As expected, increasing steric congestion around the
alkene increases the barrier to rotation due to the inherent
difficulty in passing through a hindered planar structure during
rotation.
For the derivatives 4f−i, the barrier to rotation was too high
to measure with conventional VT experiments. The 1H NMR
showed a sharp set of diastereotopic signals for the CH2 benzyl
protons, even at 373 K. It was not possible to fully resolve the
enantiomers of 4f and 4g by chiral HPLC on a variety of
columns, indicating that the atropisomers were either
inseparable on the columns examined or that they were rapidly
interconverting on the HPLC time scale; evidence for the latter
is provided vide infra. While compound 4h was partially
resolved, both enantiomers of 4i were fully resolved on a
semipreparative Whelk-O column (30.1 and 37.4 min). The
ΔG⧧298 for rotation of 4i was determined to be 25.6 kcal mol−1
by measuring the kinetics of racemization at 82 °C.43 This
suggests that a branching substituent at the sp3-hybridized α′-
position is required to generate suitable barriers to rotation for
atropisomers to be successfully separated at room temperature.
This is a similar structural motif to that found in anilides 6b (R3
≠ H, shown in red with an sp2 branching point), where barriers
to rotation were greater than 26 kcal mol−1.40 On the other
hand, structures 4b, 4f, and 4g with intermediate barriers to
rotation structurally resemble anilides 6a (R3 = H) and as a
consequence have lower barriers to rotation.39 To further study
the effects of branching at the α′-position, we prepared
structures 7a−d, investigated their resolution by chiral HPLC,
and calculated the barriers to rotation and half-lives of those
that could be resolved (Figure 4).
It was possible to fully separate the enantiomers of 7b
(containing both an α-methyl group and an α′-annulated
phenyl group) on a semipreparative Whelk-O column (37.09
and 46.47 min), and a ΔG⧧ 298 K for rotation of 27.5 kcal
mol−1 was determined by measuring the kinetics of
racemization of a 99:1 enantiomerically enriched sample at
82 °C. Compound 7b is a restricted conformational analogue of
the acyclic derivative 7a first prepared by Ahlbrecht (7a ΔG⧧ =
21.3 kcal mol−1).38 The difference in the measured barrier to
rotation is significant, δΔG⧧ = 6.2 kcal mol−1, and the relatively
low value for 7a indicates a likely cooperative gearing of the α′-
phenyl substituent rotation during the key rotation around the
N-alkenyl bond in 7a (Figure 4). The related derivative 7d gave
a single peak on the Whelk-O column, and its rotation
dynamics were not further analyzed. On the other hand, 7c
provided the highest barrier to rotation (ΔG⧧ = 31.0 kcal
mol−1, t1/2 = 99 years at 298 K, enantiomers separated at 29.0
and 31.9 min), and this barrier is comparable to published
values for o-iodoacrylanilides 6b.40 We solved the X-ray
structures of 7b and 7d, which confirmed the preference for
adoption of the amide N−CO E-rotamer geometry in the solid
state (Figure 4). The torsional angle of the key N-alkenyl bond
CC−NC(O) in 7b is 74°, which is similar to that observed
for related anilides41 and other enamides.21,42 The sum of the
angles around the nitrogen atom was 359.9°, suggesting that
the nitrogen was planar, as expected. For 7d the torsional angle
was slightly smaller, 65°. The 400 MHz 1H NMR of both 7a
and 7d in toluene-d8 showed one pair of mutually coupled
sharp doublets (for 7a, J = 14.0 Hz at 5.27 and 3.48 ppm; for
7d, J = 14.0 Hz at 5.37 and 3.37 ppm) which did not broaden
upon heating. This is consistent with the existence of largely a
single E-amide rotamer in solution, with a high barrier to
rotation around the N-alkenyl bond causing the benzyl protons
to be diastereotopic, as seen in the crystal structure of 7d.
These results suggest that enamides 1c (R1, R2, R3, R5 ≠ H, R4
= branched substituent) are likely to have sufficient barrier to
rotation around the N-alkenyl bond to be resolvable for useful
periods at room temperature.
Substitution at Nitrogen. The effect of the size of the
nitrogen substituent 8a−e on the energy barrier for N-alkenyl
bond rotation was assessed by VT NMR (Figure 5).
Deprotonation of N-1-cyclohexen-1-yl-benzeneacetamide43
with NaH in THF followed by the addition of either MeI
(8a, 84%), BuBr (8b, 70%), or iPrI (8d, 13%) furnished the
desired enamide 8a, 8b, or 8d.44 Compound 8c was prepared
by acylation of the N-benzylimine of cyclohexanone with
phenylacetyl chloride according to a literature procedure.42 We
also synthesized compound 8e by reaction of N-1-cyclohexen-
1-yl-benzene acetamide with 3 equiv of 2,6-lutidine and
TBSOTf (Figure 5).45
The moisture sensitivity of 8e required its preparation in situ
in toluene-d8 in an NMR tube, and it was not possible to isolate
a pure sample. For compounds 8a, 8b, and 8d a characteristic
change in the chemical shift of the alkene proton occurred
Figure 4. Structures 7a−d, X-ray crystal structures for 7b and 7d, and
chiral HPLC traces for 7b (ΔG⧧298 in kcal mol−1 for rotation around
the N-alkenyl bond is shown in parentheses).
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upon N-alkylation (Δδ between 0.46 and 0.70 ppm),
highlighting the loss of conjugation with the nitrogen lone
pair in 8a−d. The sense and magnitude of this shift was also
observed upon silylation in toluene-d8 (8e 4.84 ppm),
providing evidence that silylation to give 8e had occurred. As
expected, the barrier to rotation increased, 8a (10.1 kcal mol−1)
< 8b, 8c (11.5−11.7 kcal mol−1) < 8d (15.0 kcal mol−1), as the
size of the alkyl group increased, in parallel with the trend
observed in anilides 9a−d.46 In both series there is a relatively
small increase on moving from the N-methyl to N-1° alkyl
substituent (enamides 8a→ 8b δΔG⧧ = 1.6 kcal mol−1, anilides
9a → 9b δΔG⧧ = 1.0 kcal mol−1), whereas there is a
significantly larger increase for the isopropyl substituent
(enamides 8a → 8d δΔG⧧ = 4.9 kcal mol−1, anilides 9a →
9d δΔG⧧ = 5.1 kcal mol−1). This is likely due to the R group in
the N−CH2R substituent being able to rotate away from the
plane of the amide and alkene during C−N alkenyl rotation,
while this is not possible for the methyl groups N−CH(Me)2 in
8d.47 No broadening of the geminal protons of 8e was observed
on cooling to 193 K, indicating that rotation is rapid,
presumably through the O-silyl imidate 8f (Figure 5). Silylation
of related anilides has been reported to proceed to give both N-
silylated and O-silylated structures that are in rapid
equilibrium,48 and this may be occurring for enamide 8e.
The addition of radicals onto tertiary enamides (derived from
aryl bromides 10) has been reported to give tetrahydroisoqui-
nolines 11 via a 6-endo-trig radical cyclization.49 The bond
rotation dynamics of N-2-halobenzyl derivatives has not been
investigated. We briefly investigated the effect of o-halobenzyl
substituents upon the rotation barrier around the N-alkenyl
bond in related systems 13a−f (Table 1). While the effect of
such substituents X and Y might be limited (as they are three
atoms away from the nitrogen atom), the relatively large size of
bromine and iodine atoms (typically used to initiate radical
reactions or other metal-mediated cyclizations) may be
significant. The compounds 13a−g were prepared by alkylating
the known acetamide 1234 with appropriately functionalized
benzyl halides using the same approach as for 8a−e.
The introduction of a single 2-fluorine (13b) or 2-iodine
(13c) substituent had little effect on the rotation barrier; the X-
ray structure of the related 2-bromide 14 clearly showed the
halide orientated away from the alkene group, where it does not
interfere with the N-alkenyl bond rotation (Figure 6). On the
other hand, benzyl substituents containing two ortho
substituents increase the barrier to rotation in line with their
size (13d, F = +0.8 kcal mol−1; 13e, Cl = +1.6 kcal mol−1; 13f,
Br = +2.9 kcal mol−1) despite their distance from the key N-
alkenyl bond rotation. The size of the ring in which the
enamide alkene was constrained also affected the barrier to
rotation in the order 6-membered < 7-membered (compare 13f
and 15 δΔG⧧ = +1.7 kcal mol−1), which is a consequence of the
bond angles of the different ring systems.21
Substitution at the Acyl Group. Previous work with
tertiary enamides containing electron-poor and electron-rich
aromatic acyl substituents has shown that the electronic nature
of the acyl substituent has a negligible effect on the N-alkenyl
rotation barrier, suggesting that steric effects alone are
important.34 It has previously been reported that the size of
the acyl group (R) in 3a−i only moderately affects the barrier
to rotation in enamides (Figure 7).21,42 Hence, replacing an
acetyl group (3a) (ΔG⧧298 rot = 10.1 kcal mol−1) with the much
Figure 5. Effect of alkenyl substitution on the rotation barrier around
N-alkenyl bond for 8a−e (ΔG⧧298 in kcal mol−1 for rotation around
the N-alkenyl 8a−d or N-aryl 9a−d bond is shown in parentheses).
Table 1. N-Alkenyl Bond Rotation Rates from Variable-
Temperature NMR Experiments for 13a−f
compd X Y ΔG⧧298 (kcal mol−1)a
13a H H 10.138
13b F H 9.9
13c I H 9.9
13d F F 10.9
13e Cl Cl 11.7
13f Br Br 13.1
15b Br Br 14.8
aEstimated errors ΔG⧧298 ± 0.2 kcal mol−1; these are in line with
related work. bEnamide constrained in a seven-membered ring
Figure 6. Synthesis of compounds 13a−f.
Figure 7. Effect of acyl substituent 3a−i upon the ΔG⧧298 rot barriers
around the N-alkenyl bond (values in kcal mol−1 shown in
parentheses).42
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larger trichloroacetyl group (3i) (ΔG⧧298 rot = 14.2 kcal mol−1)
increases the barrier to rotation by 4.1 kcal mol−1. This steric
effect is less significant for the acyl substituent than the nitrogen
substituent [nitrogen substituent Me (8a) → iPr (8d), δΔG =
4.9 kcal mol−1; acyl substituent Me (3a)→ iPr (3d), δΔG = 1.6
kcal mol−1].42 Similar behavior has also been reported for
anilides.47
For small R substituents (such as 3a) the barrier to N-alkenyl
rotation is likely to be lower than amide N−CO rotation, but
for larger substituents (such as 3i), the barriers are likely to be
similar.19 Consequently, a number of potential mechanisms for
enantiomerization (E,M-3 → E,P-3) are possible, including
simple enamide rotation (E,M-3 → E,P-3) or a cooperative
coupled rotation of both amide and enamide, a geared process
(E,M-3 → Z,M-3 → E,P-3).50 On plotting ln krot values for 3a−
i against the cone angle (θR values)
51 of the acyl substituent, we
found a linear correlation (R2 = 0.958), which suggests that the
mechanism for rotation is likely to be the same for all of the
series and that the cone angle of the acyl substituent may be a
useful tool in predicting rotational barriers for a given series of
enamides (Figure 8).
In summary, the most important factors in controlling the
rate of N-alkenyl bond rotation in enamides is the level of
alkene substitution (particularly any branching substituent at
the α′-position), followed by the size of the nitrogen
substituent (and the distance of any branching from the
nitrogen atom) and, finally, the size of the acyl substituent.
Radical Cyclization Substrate Dynamics. The radical
cyclization of α-haloenamides 16−18 is well-documented and
may proceed via a 4-exo or 5-endo cyclization, depending upon
the substrate (Figure 9).52−64 Rotational features of enamides
can dictate the success or failure of radical cyclizations, with the
E-amide rotamer being required.30 In general, 1-substituted
enamides 16 cyclize via a 5-endo pathway (R2 = Ph or
CO2R),
52−55 while 2- or 2,2-substituted enamides 17 proceed
via a 4-exo pathway,56−58 although electronic factors and
temperature can also play a part in controlling the
regiochemistry for these substrates.58−60 By far the majority
of cyclization reactions reported involve 1,2-substituted
enamides 18, which generally proceed via a 5-endo path-
way.59−70 For cyclization of radicals derived from homolysis of
the C−Br bond in substrates 3c and 3h,66−70 it is necessary for
a twisting to occur in the transition state so that the radical
SOMO and alkene LUMO orbitals can overlap efficiently, and
this has been confirmed by calculations.71 As a consequence,
the twisted ground state of molecules such as 3c and 3h likely
facilitate cyclization with a movement toward planarity
occurring during the reaction (Figure 9). Far less is known
about cyclizations of 1,2,2-substituted enamides, where move-
ment toward planarity during cyclization may be hindered due
to steric effects.59,60,72
Cyclization of 19 was reported to be unsuccessful using
Bu3SnH at 80 °C, while cyclization of the analogue 21 gave
both 4-exo 23 and 5-endo products 22, depending upon the
temperature (Figure 10).72 This suggests that the 4-exo
cyclization process was reversible, and at the higher temper-
ature, 5-endo cyclization followed by irreversible loss of the
phenylthiyl radical predominated to give 22. From our studies
above it is apparent that these substrates are likely to have
ground-state N-alkenyl bond rotation barriers of less than 20
kcal mol−1.
To the best of our knowledge the cyclization of enamides
containing further branching at the α′-position have not been
studied in detail (Figure 10). For these substrates, where
barriers to rotation around the N-alkenyl bonds are likely to be
significant (>20 kcal mol−1), it is unclear if cyclization would be
efficient because steric interactions would develop as the radical
and radical acceptor move toward planarity during the
cyclization process. In order to address these issues, we
prepared enamides 24−28, examined their barriers to rotation
and investigated their radical cyclization reactions (Figure 11).
Figure 8. Correlation between cone angle θR and ln krot values for 3a−
i (R2 = 0.958).
Figure 9. Regiochemical modes of cyclization of α-haloenamides.
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The most commonly used protocols for mediating radical
cycl izations of α -haloenamides are (i) Bu3SnH/
AIBN,52−54,62−65 where chlorides provide higher yields of
cyclized products than bromides or iodides,70 and (ii)
copper(I) complexes of bipyridine,57 hexamethyltriethylenedi-
amine,66 or tripyridylamine,56,57,67−69 which work for trichlor-
oacetamide or tertiary halide derivatives only (Bu3SnH, R =
CH2Cl, CH2Br, CH2I; Cu(I), R = CCl3, CMe2Br).
64
Consequently, we tested α-haloenamides 24−28 under a
range of conditions and determined the regiochemistry of
their radical cyclization reactions (Figure 11). It was not
possible to fully resolve the atropisomers of 24−26, despite the
large acyl substituents. We believe this is indicative of individual
isomers interconverting on the HPLC time scale at room
temperature. Evidence for this assumption can be obtained
from the HPLC chromatogram for compound 26a, which is
indicative of the individual enantiomers interconverting at
room temperature (Figure 12d). The ΔG⧧ value for rotation
for 26a was estimated to lie between 21 and 23 kcal mol−1
based upon a half-life of minutes at 298 K. In all these cases, the
cooperative gearing of the phenyl substituent during N-alkenyl
bond rotation is likely to lower the observed barrier to
rotation.73
For relatively large acyl substituents (25b, 26b, R = CCl3;
25c, 26c, R = CMe2Br) the barrier for N−(CO) amide bond
rotation was found to be lower than that of N-alkenyl bond
rotation (Figure 12b).
Analysis of the 400 MHz 1H NMR of 25b,c and 26b,c at 298
K showed a doubling of all peaks (Figure 12a), indicative of
both (E)- and (Z)-amide rotamers at room temperature (while
25a or 26a only showed one set of peaks). The ratio of amide
rotamers obtained from the 400 MHz 1H NMR at room
temperature was similar for the two trichloroacetyl derivatives
(25b E:Z = 1.0:0.25 and 26b E:Z = 1.0:0.26) and the two
bromo derivatives (25c E:Z = 1.0:0.65 and 26c E:Z = 1.0:0.62),
indicating that the population of the two rotamers was dictated
by the acyl substituent. Heating either 25b,c or 26b,c at 373 K
led to coalescence of the four sets of doublets to two broad
singlets, indicative of a rapid interconversion on the NMR time
scale between the (E)- and (Z)-amide rotamers with a slower
rotation around the enamide N−C bond (Figure 12a). The
barrier to rotation around the N−(CO) amide bond is known
to be influenced by the acyl substituent with sterically
demanding (t-Bu) groups lowering the barrier by 4−5 kcal
mol−1 compared to simple acetamide derivatives.74 The X-ray
crystal structure of 25c clearly shows the (Z)-amide rotamer in
the solid state (Figure 12c). A similar doubling of signals was
also observed in the 1H NMR of the related structure 27c
(1:0.17). Thus, for enamides containing four alkenyl sub-
stituents, the (E)-geometry is favored in both solution (CDCl3)
and the solid state for relatively small primary acyl groups (R =
Me, CH2Cl, CH2Br, cone angles 112°−130°), but mixtures of
both (E)- and (Z)-amide rotamers can be detected in solution
if larger acyl groups or strongly electron withdrawing groups (R
= CMe2Br, CCl3, cone angles 153°−160°) are present.
It was possible to fully separate the enantiomers of 27a−c on
a semipreparative Whelk-O column, allowing for barriers to
rotation to be calculated (27a, er = 99:1, ΔG⧧ = 27.8 kcal
Figure 10. Regiochemical modes of cyclization of 1,2,2-substituted α-
haloenamides.
Figure 11. Structures 24−28 showing the ΔG⧧298 rot barriers around
the N-alkenyl bond in parentheses (values in kcal mol−1).
Figure 12. (a) Expansion of the benzylic region of the 400 MHz 1H
NMR spectra of 25c in toluene-d8 at 298 and 373 K. (b) Cooperative
rotation of amide N−(CO) bond during N-alkenyl bond rotation. (c)
X-ray crystal structure of 25c. (d) Chiral HPLC chromatogram of 26a.
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mol−1, t1/2 = 163 days at 298 K; 27b, er =98:2, ΔG⧧ = 29.3 kcal
mol−1, t1/2 = 5.6 years at 298 K; 27c, er = 87:13, ΔG⧧ = 25.6
kcal mol−1, t1/2 = 4 days at 298 K), suggesting that these
compounds would make interesting substrates with which to
investigate chirality transfer during 5-endo-trig radical cycliza-
tion reactions at room temperature. If cyclization is significantly
more rapid than N-alkenyl bond rotation, then chirality transfer
from individual atropisomers is theoretically possible.1 Radical
cyclizations of related axially chiral o-haloanilides have been
shown to proceed with high levels of chirality transfer from the
chiral axis to the newly formed stereocenter.39,40,75−79 If,
however, elevated temperatures are necessary for cyclization
(e.g., 80 °C), then only bromide 27b or iodide 27d are likely to
exhibit a suitable barrier to rotation (27b t1/2 = 18.5 h at 353 K)
compared to 27a (2 h) and 27c (7 min). It is interesting to
observe that 27c has a lower barrier to N-alkenyl bond rotation
than either 7b or 27a,b despite having a larger acyl substituent.
The fact that it exists as a mixture of (E)- and (Z)-amide
isomers in solution suggests that the lower N-alkenyl barrier
may be due to a cooperative gearing with rotation of the amide
functional group. However, in anilides it has been reported that
the steric repulsion between bulky substituents causes
pyramidalization of amide nitrogen and twisting of the amide
bond (destabilization of the ground state) to bring about the
decrease in the rotational barrier around an N−C chiral axis.73
While we cannot disprove that this is the reason for the lowered
barrier of 27c, it is unlikely, as the related substrate 25c shows
no such pyramidization in its X-ray structure (Figure 12c).
Radical Cyclization Reactions. We have previously shown
that a slow syringe pump addition of Bu3SnH/AIBN to the
chloride 3j produces mainly 33 (92%) from reduction of the
cyclized radical 30 (Figure 13).66 Reactions of the bromide 3c
and iodide 3k proceed differently. While the bromide 3c gave
33 as the major product (55%), the alkene regioisomers 34
(11%) and 35 + 36 (11%) were also isolated. The iodide 3k
gave the uncyclized material 32 (68%) as the major product
with 34 (11%) and 35 + 36 (13%). The different product ratios
were explained via a competing electron transfer from the
intermediate radical 30 to the starting halides 3c and 3k, giving
the acyl iminium ion 31. Elimination of a proton from 31
produces the three alkene regioisomers 34−36. The higher
ratio of reduced product 32 from the iodide 3k was shown to
be due to a competing nonradical deiodination process.70
By analogy, we initially chose to investigate the Bu3SnH-
mediated cyclization of the primary chlorides 26a, 27a, and 28
representing varying levels of hindrance to rotation around the
N-alkenyl bond. The chlorides were chosen to suppress
products arising from electron transfer from the cyclized
radical to the starting chloride.
When a 0.02 M solution of 26a (ΔG⧧298 rot ∼ 21−23 kcal
mol−1) was treated with 1.5 equiv of Bu3SnH and 0.2 equiv of
ACN at reflux for 26 h, the major product was the uncyclized
compound 7d (30%), suggesting a relatively slow cyclization,
which is in line with that previously reported for 19. Significant
starting material 26a was also recovered (21%).72 The expected
cyclized product 37a was obtained in 27% yield, arising from a
5-endo-trig cyclization followed by Bu3SnH-mediated reduction
(no 4-exo products were isolated). A significant amount of the
hydroxyl terminated compound 37b (17%) was also detected.
Presumably, alcohol 37b arises via a radical−polar crossover
reaction with trapping of the intermediate acyl iminium ion
with water (upon workup), there being no elimination pathway
analogous to 31 → 34−36 available for 26a (Figure 14).
Attempts to cyclize derivatives with higher barriers to rotation
(27a, ΔG⧧298 rot = 27.8 kcal mol−1; 28, ΔG⧧298 rot > 31.0 kcal
Figure 13. Formation of products from 5-endo cyclization of 3c, 3h, 3j, and 3k.
Figure 14. Reaction of 26a and 27a with Bu3SnH.
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mol−1) failed, presumably due to the increased difficulty in
moving to planarity during the cyclization. Reaction of the
chloro derivative 27a with Bu3SnH (0.01M) and Et3B
79 at
room temperature led to recovered starting material 27a (44%)
and the reduced substrate 7b being isolated (70% based upon
recovered starting material). On the other hand, addition of 1.5
equiv of Bu3SnH and 20 mol % AIBN (via a syringe pump
addition for 2 h, initial concentration 0.01 M) led to oxidation
to the naphthalene 38a in 19% yield (47% based upon
recovered starting material). Complete oxidation to the
naphthalene 38a could also be accomplished if 27a was reacted
with 2 equiv of AIBN in the absence of Bu3SnH, indicating that
the radical initiator was responsible for the oxidation and that
this process was more rapid than homolytic fission of the C−Cl
bond.80−82 The same oxidation to give 38b was observed for
the iodide 27d. In order to enhance the rate of radical initiation
over that of oxidation, we investigated the reaction of the
bromide 27b. Over 18 h, 1.5 equiv of Bu3SnH and 0.2 equiv of
ACN were added via a syringe pump to a 0.12 M solution of
the bromide 27b under nitrogen in dry toluene at reflux. Thin
layer chromatography revealed that significant amounts of
starting material remained after 24 h, indicative of a slow
initiation, so further Bu3SnH/ACN was added. Three further
aliquots of the initiator (1 equiv in total) over 48 h were
required for complete consumption of the starting material.
Upon workup, three products were isolated: the uncyclized
acetamide 7b (42%), the naphthanilide 38c (7%), and the
ketone 39a (10%), arising from oxidative cleavage of the
tetralone ring (Figure 15). Repeating the reaction using
degassed toluene, in a Schlenk tube under argon, led to
suppression of 39a (trace amounts), and only the naphthanilide
38c was isolated (along with recovered starting material).
Although the mechanism for the formation of 39a remains
unclear, the oxidative α-C−C bond cleavage of 2-substituted 1-
tetralones to give 40 under radical conditions (TEMPO) has
been reported.83 The mechanism has been reported to involve
addition of oxygen to give an α-hydroperoxide. Radical or
anionic fragmentation, Baeyer−Villiger/Criegee fragmentation,
or base-induced fragmentation of the peroxide can all
potentially lead to the observed products (although a
theoretical study indicates that a radical fragmentation is
most likely).83
In order to remove the complication of undesired tetralone
cleavage, the reaction of 28 was investigated where the
analogous oxidation was not possible. Reaction with Bu3SnH
and ACN led to formation of uncyclized 7c in 88% yield as the
sole product.
While it is most common to carry out Bu3SnH-mediated
reactions at elevated temperatures (typically benzene or toluene
at reflux), efficient 5-endo radical−polar crossover reactions (3h
→ 35 and 36 R = Me) mediated by Cu(I) complexes have been
reported at room temperature for tertiary halides 3h (Figure
13).66 The ability to conduct such cyclizations at lower
temperature is attractive if chirality transfer during reaction of
individual atropisomers is to be studied. Another advantage of
generating the reactive radical from homolysis of a C−X bond
via a Cu(I)-mediated atom transfer is that this initiating process
is reversible, effectively providing longer “lifetimes” and less
reduction of precyclized radicals than alternative Bu3SnH-
mediated processes. As before, the cyclization of substrates with
ΔG⧧298 rot < 26 kcal mol−1 proceeded smoothly, albeit at
elevated temperatures. Reaction of 24a with either 30 mol % of
Cu(Me6-tren)Cl or Cu(TPMA)Cl in toluene or DCM at room
temperature only led to trace amounts of 41a (<5%) after 48 h.
On the other hand, heating of 24a with 1 equiv of Cu(TPMA)
Cl in toluene at reflux led to complete conversion to 41a in
70% yield. We next investigated the cyclizations of 25b and 26b
using the optimum conditions determined for 24a [100 mol %
Cu(TPMA)Cl], Figure 16.
Cyclization of both substrates was complete in 2 h and
produced the expected dichlorides 42a and 43a along with the
monochlorides 42b and 43b as single diastereomers (assigned
from the 1H NOE difference spectrum of 43b). Both sets of
products arose from trapping of the intermediate acyl iminium
ion by water (as seen for the Bu3SnH reaction of 26a). The
monochloride 42b is likely formed by reduction of the α-amide
radical obtained from a second atom transfer from 42a to
Cu(TPMA)Cl or by electron transfer from the cyclized radical
to 42a (the driving force being the relief of the eclipsing
Figure 15. Attempted cyclization of 27b with Bu3SnH.
Figure 16. Cu(TPMA)Cl-mediated 5-endo cyclization of 24a, 25b, and
26b, showing NOE enhancements (in percent) for 43b.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.6b00889
J. Org. Chem. 2016, 81, 5547−5565
5554
interactions between the gem-dichloride group and the
neighboring quaternary center).
Reaction of 25c with 1 equiv of Cu(TPMA)Br in toluene at
reflux for 10 h produced three products, 44, 45, and 46, in 36%,
15%, and 4% isolated yields, respectively (Figure 17). The
major product 44 arises via the intermediate acyl iminium ion
47, as previously observed for 25b, while the reduced product
45 may arise from abstraction of a hydrogen atom from toluene
by the cyclized radical. This would indicate that electron
transfer in the radical−polar crossover step was slower than in
the trichloroacetyl derivatives 25b and 26b. The formation of
the cyclopropyl compound 46 deserves comment. There is a
significant steric clash between the C-3 and C-4 gem-dimethyl
groups in the acyl imimium ion intermediate 49. In order to
relieve these clashes, torsion of the C-3 to C-4 C−C bond can
occur, which places the C-4 pseudoaxial methyl group almost
parallel to the p-orbital of the acyl iminium ion 49, initiating a
rearrangement to form a protonated cyclopropane intermediate
48. Formation of a cyclopropane by loss of a proton during a
1,2-migration of a methyl group has been previously
reported,84,85 and this process would give rise to the observed
product 46. More of the cyclopropyl derivative was isolated
from the analogous reaction of 26c (50, 51, and 52 being
formed in 33%, 21%, and 5% yields, respectively). Presumably,
the more-electron-rich nature of the methylene group in 26c
compared to the methyl group in 25c is responsible for the
greater yield of trapped migration product 51 (Figure 18).
Reaction of the tetralone derivative 27c was relatively slow
compared to the other substrates (25c and 26c) and required
heating at reflux for 44 h with 1.2 equiv of Cu(TPMA)Br
before all the starting material was consumed. This substrate
exhibited the highest barrier to N-alkenyl bond rotation of the
substrates cyclized using Cu(TPMA)Br. Two products were
isolated, the expected cyclized product 53 and the oxidatively
ring-opened compound 39b (in a 2:1 ratio). Repeating the
reaction in a Schlenk tube with degassed solvent (three freeze−
thaw cycles) suppressed the formation of 39b to trace levels
(<2%), indicating that dissolved O2 was most likely responsible
for mediating the unusual ring-opening process to give 39b.
The reaction was more efficient, requiring less copper reagent
(0.6 equiv) and a shorter reaction time (15 h). In addition, two
further products, 54 and 55, were isolated in 31% and 7%,
respectively (although it was not possible to obtain 55
completely free of impurities) (Figure 19). Unfortunately,
attempts to conduct the reaction of 27c at a lower temperature
(353 K) provided trace levels of cyclized products only, while
the barrier to rotation around the N-alkenyl bond of 27c at 383
K was too low (t1/2 = 18 s) to warrant investigating whether
chirality transfer from one atropisomer to the cyclized products
was possible.
As with the formation of 39a, from the Bu3SnH-mediated
reaction of 27b, the mechanism for the formation of 39b
remains unclear, although the oxidative α-C−C bond cleavage
of 2-substituted 1-tetralones with either CuCl or CuCl2 and
amine bases in the presence of O2 has been reported.
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■ CONCLUSIONS
In conclusion, we have prepared 38 different enamides 1c
varying in the substitution around the acyl group 1 (R2 ≠ H),
the nitrogen substituent (R1 ≠ H), and alkene substituents (R3,
R4, R5 ≠ H). The majority show slow rotation around the N-
alkenyl bond of the enamide with ΔG⧧298 rot barriers varying
between <8.5 and 31.0 kcal mol−1. The most important factor
in controlling the rate of rotation is the level of alkene
substitution (R3, R4, R5), followed by the size of the nitrogen
substituent (R1) and, finally, the size of the acyl substituent
(R2). Electronic effects are small for substituents positioned on
the acyl group (R2), and the rate of rotation was linearly
correlated with the cone angle of the substituent for the studied
series 3a−i, indicating that the mechanism of rotation was likely
to be the same for all the compounds. For N-benzyl groups
13a−f, o-halo-substitution has little effect on the barrier to
rotation, except where two ortho substituents are present,
indicating that cooperative gearing of the nitrogen substituent is
likely during the N-alkenyl rotation. A similar gearing for freely
Figure 17. Cu(TPMA)Br-mediated 5-endo cyclization of 25c.
Figure 18. Products from Cu(TPMA)Br-mediated 5-endo cyclization
of 26c.
Figure 19. Reactions of 27c with Cu(TPMA)Br.
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rotatable α-substituents (Ph in 7a) is also indicated. Tetra-
substituted alkenes possessing rigid α,α′-substituents (7b,c)
have high enough barriers to rotation at room temperature to
be separated by chiral HPLC with half-lives of up to 99 years at
298 K. This should theoretically enable future investigations
into asymmetry transfer from enantiomerically pure enamides
in a range of synthetic processes. For enamides 25b,c, 26b,c,
and 27c containing large or electron-withdrawing acyl groups
(cone angles θR > approximately 130°) both (E)- and (Z)-
amide rotamers were detected in solution at room temperature.
Interconversion of these two rotamers was found to be fast on
the NMR time scale at 80 °C for all the examples studied. An
examination of the barriers to rotation for the series 7b and
27a−c shows that while there is a steady increase between with
increasing size of the acyl substituent, as expected (7b, ΔG⧧298
27.5 kcal mol−1; 27a, ΔG⧧298 27.8 kcal mol−1; 27b, ΔG⧧298 29.3
kcal mol−1), there is a significant drop for 27c (ΔG⧧298 25.6
kcal mol−1), indicative of a cooperative gearing effect between
rotation around the (E)- and (Z)-amide and (M)- and (P)-
enamide rotamers with larger acyl substituents. This provides
important temperature constraints when attempting asymmet-
ric reactions of similar enamides.
While radical cyclization of enamides 3h−j with relatively
low barriers to rotation around the N-alkenyl bond (ΔG⧧298 rot
= 13−14 kcal mol−1) can be accomplished at room temper-
ature,66 in this study those with higher barriers (ΔG⧧298 rot >
∼20 kcal mol−1) required elevated temperatures, presumably
due to the extra steric crowding hindering these molecules
movement toward planarity during cyclization. Molecules with
very high barriers to rotation (ΔG⧧298 rot > ∼26 kcal mol−1) did
not undergo radical cyclization with Bu3SnH; instead,
precyclization reduction or alternative reaction pathways
predominated. For molecules with intermediate barriers to
rotation (ΔG⧧298 rot ∼ 20−26 kcal mol−1), highly functionalized
γ-lactams were produced via a 5-endo-trig radical−polar
crossover process and terminated either by reduction, an
unusual cyclopropanation sequence, or trapping with H2O,
depending upon the reaction conditions. Steric congestion in
cyclized products derived from trichloroacetamide derivatives
25b and 26b was relieved by a competing second atom transfer
and reduction leading to replacement of one α-chloro
substituent with a hydrogen atom (42b and 43b). Unfortu-
nately, because elevated temperatures were necessary for
cyclization of substrates, in this study it precluded the
examination of asymmetric transfer in the reaction of individual
atropisomers such as 27d. However, this report does indicate
that enantiomerically enriched atropsiomeric tertiary enamides
should be regarded as potential asymmetric building blocks for
reactions that can be accomplished at room temperature or
below and may be useful functional groups in molecular
machines and gears.1
■ EXPERIMENTAL SECTION
General Methods. 1H NMR spectra were recorded at 300, 400,
500, or 700 MHz and 13C NMR spectra were recorded at 75.5, 100,
125, or 175 MHz with residual solvent as standard; infrared (IR)
spectra were recorded as neat solutions or solids; and low- and high-
resolution mass spectra were recorded using the electrospray
ionization technique and a TOF mass analyzer.
Synthesis of Known Compounds by Literature Methods.
Butan-2-one oxime,86 3-methylbutan-2-one oxime,87 isobutyraldehyde
oxime,88 2-methyl-1-tetralone oxime,89 2-methyl-1-phenylpropan-1-
one oxime,39 cyclohexyl(phenyl)methanone oxime,39 2-phenylcyclo-
hexanone oxime,90 2,2,6-trimethylcyclohexanone oxime,91 2,4-dimeth-
yl-3-pentanone oxime,92 and N-benzyl-N-(prop-1-en-2-yl)acetamide
(4a)32 were prepared by literature procedures and exhibited 1H and
13C NMR spectroscopic details identical to those previously reported.
1H NMR was used to check the purity of all the compounds.
General Procedure for the Formation of Enamides 2b,
24a,b, 25b,c, 26b,c, via Imines, Method A. Ketone (1 equiv) and
benzylamine (1.0 equiv) with or without TsOH were dissolved in dry
toluene and heated to reflux under Dean−Stark conditions for 4−16 h.
The reaction mixture was then cooled to 0 °C. Triethylamine (1.2
equiv) was then added slowly, followed by the dropwise addition of
the appropriate acid chloride (1.1 equiv). The reaction mixture was
allowed to warm to room temperature and stirred for 12 h. NaHCO3
(∼50 mL) was added, and the layers were separated. The aqueous
phase was extracted with Et2O (3 × 50 mL), and the organic layers
were combined, dried over MgSO4, filtered, and concentrated in vacuo
to give the crude product. Products were purified by column
chromatography.
N-Benzyl-N-vinylacetamide (2b).93 Conditions: acetaldehyde (2.0
g, 45.4 mmol), benzylamine (4.96 mL, 45.4 mmol), toluene (45 mL,
90 mL), triethylamine (7.6 mL, 54.5 mmol), and acetyl chloride (3.6
mL, 49.9 mmol). Yield 1.3 g (15%); yellow oil; mixture of amide
rotamers (ratio 2:1); Rf 0.45 (pet. ether:EtOAc, 4:1); IR υmax (film)/
cm−1 2039, 1670, 1619; discernible data for major rotamer, 1H NMR
δH (CDCl3, 600 MHz) 7.17−7.36 (5H, m), 6.86 (1H, dd, J 15.5, 9.0
Hz), 4.90 (2H, s), 4.46 (1H, d, J = 15.5 Hz), 4.33 (1H, dd, J = 9.0 Hz),
2.34 (3H, s); 13C NMR δC (CDCl3, 151 MHz) 169.6, 136.9, 133.3,
128.5, 127.0, 126.8, 95.3, 45.4, 22.1; discernable data for minor
rotamer, 1H NMR δH (CDCl3, 300 MHz) 7.63 (1H, dd, J = 16.0, 9.5
Hz), 7.17−7.36 (5H, m), 4.78 (2H, s), 4.38−4.42 (2H, m), 2.18 (3H,
s); 13C NMR δC (CDCl3, 151 MHz) 169.9, 136.0, 131.8, 128.9, 127.4,
125.6, 94.7, 48.7, 22.4; data for mixture, MS m/z (ESI) 198.1
([M]+Na).
N-Benzyl-2,2,2-trichloro-N-(2-phenylcyclohex-1-enyl)acetamide
(24a).94 Conditions: 2-phenylcyclohexanone (2.43 g, 13.9 mmol),
benzylamine (1.52 mL, 13.9 mmol), toluene (15 mL, then 25 mL),
triethylamine (2.32 mL, 16.7 mmol), and trichloroacetyl chloride (1.71
mL, 15.3 mmol). Yield 1.18 g (21%); white crystalline solid; mp 116−
118 °C; Rf 0.52 (pet. ether:EtOAc, 14:1); IR υmax (film)/cm
−1 2924,
1671; 1H NMR δH (CDCl3, 700 MHz) 7.38−7.22 (10H, m), 5.17
(1H, d, J = 14.0 Hz), 3.55 (1H, d, J = 14.0 Hz), 2.44 (1H, apparent d, J
= 18.0 Hz), 2.34 (1H, apparent d, J = 17.0 Hz), 2.17−2.26 (1H, m),
1.64−1.73 (1H, m), 1.49−1.59 (1H, m), 1.31−1.41 (1H, m), 1.20−
1.30 (1H, m), 1.06−1.16 (1H, m); 13C NMR δC (CDCl3, 175 MHz)
159.5, 140.3, 135.4, 135.2, 134.9, 129.5, 128.8, 128.4, 128.3, 127.7,
127.4, 93.7, 53.4, 31.3, 29.0, 22.6, 22.5; MS m/z (ESI) 430.0
([M]+Na) [found ([M]+Na) 430.0502, C21H20Cl3NNaO requires
430.0503].
N-Benzyl-2-bromo-2-methyl-N-(2-phenylcyclohex-1-enyl)-
propanamide (24b). Conditions: 2-phenylcyclohexanone (2.43 g,
13.9 mmol), benzylamine (1.52 mL, 13.9 mmol), toluene (15 mL,
then 25 mL), triethylamine (2.32 mL, 16.7 mmol), and 2-
bromoisobutyryl bromide (1.89 mL, 15.3 mmol). Yield 716 mg
(13%); white crystalline solid; mp 83−86 °C; Rf 0.33 (pet.
ether:EtOAc, 14:1); IR υmax/cm
−1 2940, 1626; 1H NMR δH (CDCl3,
700 MHz) 7.17−7.41 (10H, m), 5.33 (1H, d, J = 14.0 Hz), 3.47 (1H,
d, J = 14.0 Hz), 2.39 (1H, apparent d, J = 17.5 Hz), 2.32 (1H, apparent
d, J = 17.0 Hz), 2.12−2.23 (1H, m), 2.07 (3H, s), 1.82 (3H, s), 1.62−
1.71 (1H, m), 1.48−1.60 (1H, m), 1.28−1.39 (1H, m), 1.17−1.27
(1H, m), 1.05−1.16 (1H, m); 13C NMR δC (CDCl3, 175 MHz) 169.7,
141.2, 136.3, 136.0, 134.1, 129.5, 129.2, 128.6, 128.6, 128.5, 128.2,
127.6, 127.4, 57.4, 52.8, 33.9, 31.6, 31.3, 29.6, 22.7, 22.6; MS m/z
(ESI) found ([M]+Na) 434.1087, C23H26BrNNaO requires 434.1090.
N-Benzyl-2,2,2-trichloro-N-(2-methyl-1-phenylprop-1-enyl)-
acetamide (25b). Conditions: isobutyrophenone (5.06 mL, 33.8
mmol), benzylamine (3.69 mL, 33.8 mmol), TsOH (1.92 g, 10.1
mmol), toluene (35 mL then 15 mL), triethylamine (1.40 mL, 10.1
mmol), and 2-bromoisobutyryl bromide (1.15 mL, 9.27 mmol). Yield
1.21 g (38%), as a 1.00:0.26 mixture of rotamers; colorless crystalline
solid; mp 68−69 °C; Rf 0.51 (pet. ether:EtOAc, 19:1); IR υmax/cm−1
2913, 1680; 1H NMR δH (CDCl3, 300 MHz) 7.51−7.08 (10H minor
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+ 8H major rotamers, m), 7.02 (2H major rotamer, dd, J = 8.0, 1.5
Hz), 5.41 (1H major rotamer, d, J = 14.5 Hz), 5.05 (1H minor
rotamer, d, J = 13.5 Hz), 4.13 (1H major rotamer, d, J = 14.5 Hz), 3.85
(1H minor rotamer, d, J = 13.5 Hz), 1.80 (3H minor rotamer, s), 1.60
(3H major rotamer, s), 1.55 (3H major rotamer, s), 1.29 (3H minor
rotamer, s); 13C NMR δC (CDCl3, 75 MHz) 159.4, 136.5, 135.3,
134.7, 130.9, 129.7, 129.2, 128.9, 128.2, 128.1, 127.6, 94.1, 53.5, 21.8,
21.0; MS m/z (ESI) found ([M]+Na) 404.0346, C19H18Cl3NNaO
requires 404.0352.
N-Benzyl-2-bromo-2-methyl-N-(2-methyl-1-phenylprop-1-enyl)-
propanamide (25c). Conditions: isobutyrophenone (5.06 mL, 33.8
mmol), benzylamine (3.69 mL, 33.8 mmol), TsOH (1.92 g, 10.1
mmol), toluene (35 mL then 15 mL), triethylamine (1.40 mL, 10.1
mmol), and 2-bromoisobutyryl bromide (1.15 mL, 9.27 mmol). Yield
2.39 g (74%) as a 1.0:0.6 mixture of rotamers; pale yellow crystalline
solid; mp 74−76 °C; Rf 0.37 (pet. ether:EtOAc, 6:1); IR υmax/cm−1
2989, 1639; 1H NMR δH (CDCl3, 400 MHz) 7.56−7.10 (10H minor,
8H major rotamers, m), 7.00 (2H major rotamer, d, J = 7.0 Hz), 5.53
(1H major rotamer, d, J = 15.0 Hz), 5.11 (1H minor rotamer, d, J =
13.5 Hz), 4.18 (1H major rotamer, d, J = 15.0 Hz), 3.80 (1H minor
rotamer, d, J = 13.5 Hz), 2.22 (3H major rotamer, s), 2.14 (3H major
rotamer, s), 2.08 (3H minor rotamer, s), 2.06 (3H minor rotamer, s),
1.86 (3H minor rotamer, s), 1.64 (3H major rotamer, s) 1.62 (3H
major rotamer, s), 1.29 (3H minor rotamer, s); 13C NMR δC (CDCl3,
175 MHz) mixture 171.9, 169.2, 137.5, 136.5, 135.9, 134.4, 134.1,
133.3, 131.6, 130.2, 130.2, 129.7, 128.9, 128.4, 128.1, 127.9, 127.6,
127.5, 127.1, 62.3, 57.9, 53.2, 53.1, 33.9, 33.5, 33.4, 32.7, 21.9, 21.8,
21.0, 20.9; MS m/z (ESI) found ([M]+Na) 408.0933, C21H24BrNNaO
requires 408.0939.
N-Benzyl-2,2,2-trichloro-N-(cyclohexylidene(phenyl)methyl)-2-
methylacetamide (26b). Conditions: cyclohexylphenyl ketone (1.5 g,
8.0 mmol), benzylamine (0.87 mL, 38.0 mmol), TsOH (303 mg, 1.6
mmol), toluene (9 mL then 15 mL), triethylamine (1.33 mL, 9.6
mmol), and trichloroacetyl chloride (0.98 mL, 8.8 mmol). Yield 1.46 g
(43%) as a 1.00:0.26 mixture of rotamers; cream crystalline solid; mp
128−129 °C; Rf 0.54 (pet. ether:EtOAc, 6:1); IR υmax/cm−1 2972,
1671; 1H NMR δH (toluene-d8, 400 MHz) 7.41−6.98 (10H, m), 5.31
(1H major rotamer, d, J = 14.5 Hz), 5.06 (1H minor rotamer, d, J =
14.5 Hz), 3.92 (1H major rotamer, d, J = 14.5 Hz), 3.64 (1H minor
rotamer, d, J = 14.5 Hz), 2.44 (1H minor rotamer, br s), 2.10−2.08
(2H major rotamer, m), 1.63−0.90 (8 major + 8 H minor rotamer, m),
0.30 (1H minor rotamer, m); 13C NMR δC (CDCl3, 100 MHz) 159.6,
141.7, 136.3, 135.0, 130.6, 130.4, 129.8, 129.4, 128.5, 128.3, 128.3,
128.2, 127.7, 94.2, 53.3, 31.0, 27.7, 26.6, 26.4; MS m/z (ESI) found
([M]+Na) 444.0659, C22H22Cl3NNaO requires 444.0665; HPLC
(S,S)-Whelk-O1 (25 cm × 4.6 mm) hexanes:iPrOH (1.0 mL/min)
tR 4.09 min.
N-Benzyl-2-bromo-N-(cyclohexylidene(phenyl)methyl)-2-methyl-
propanamide (26c). Conditions: cyclohexylphenyl ketone (1.5 g, 8.0
mmol), benzylamine (0.87 mL, 38.0 mmol), TsOH (303 mg, 1.6
mmol), toluene (9 mL then 15 mL), triethylamine (1.33 mL, 9.6
mmol), and 2-bromoisobutyryl bromide (1.08 mL, 8.8 mmol). Yield
2.02 g (59%) as a 1.0:0.6 mixture of rotamers; pale brown crystalline
solid; mp 102−104 °C; Rf 0.43 (pet. ether:EtOAc, 14:1); IR υmax/cm−1
2973, 1656; 1H NMR δH (CDCl3, 400 MHz) 7.50−7.21 (10H minor
+ 8H major rotamers, m), 7.01 (2H major rotamer, d, J = 7.0 Hz), 5.52
(1H major rotamer, d, J = 14.5 Hz), 5.16 (1H minor rotamer, d, J =
13.5 Hz), 4.02 (1H major rotamer, d, J = 14.5 Hz), 3.63 (1H minor
rotamer, d, J = 13.5 Hz), 2.70−2.67 (1H minor rotamer, m), 2.19 (3H
major rotamer, s), 2.10 (3H major rotamer, s), 2.06 (6H minor
rotamer, s), 2.12−1.08 (9H major + 8H minor rotamers, m), 1.03−
0.80 (1H major rotamer, m), 0.34−0.26 (1H minor rotamer, m); 13C
NMR δC (CDCl3, 100 MHz) data for mixture of rotamers 172.2,
169.4, 141.3, 140.5, 137.3, 136.7, 136.4, 136.1, 131.4, 130.1, 129.8,
129.1, 128.6, 128.3, 128.2, 128.1, 127.7, 127.2, 62.9, 57.9, 52.9, 33.7,
32.8, 32.2, 31.6, 31.0, 27.8, 27.6, 26.7, 26.5; MS m/z (ESI) found
([M]+Na) 448.1246, C24H28BrNNaO requires 448.1252; HPLC (S,S)-
Whelk-O1 (25 cm × 4.6 mm) hexanes:iPrOH (1.0 mL/min) tR 5.41
min.
N-Benzyl-2-bromo-2-methyl-N-(2-methyl-3,4-dihydronaphtha-
len-1-yl)propanamide (27c). 2-Methyl-1-tetralone (1.00 g, 6.24
mmol), benzylamine (0.818 mL, 7.49 mmol), and titanium
isopropoxide (2.77 mL, 9.36 mmol) were heated to 80 °C for 48 h.
The reaction mixture was then cooled to room temperature and
toluene (12 mL) was added. The resulting solution was then cooled
further to 0 °C, triethylamine was added (1.30 mL, 9.36 mmol),
followed by the dropwise addition of 2-bromoisobutyryl bromide
(0.93 mL, 7.49 mmol), and the reaction mixture was stirred at room
temperature for 14 h. Saturated ammonium chloride (15 mL) was
then added, and the phases were separated. The organic phase was
diluted with toluene (20 mL) and washed with 2 M HCl (3 × 30 mL),
dried over MgSO4, filtered, and concentrated in vacuo to give the
crude product as a brown oil (1.26 g). The crude product was purified
by column chromatography (14:1, pet. ether:EtOAc) to give the
product as a light brown oil (144 mg, 6%) as a 6:1 mixture of amide
rotamers. Rf 0.17 (pet. ether:EtOAc, 14:1); IR υmax/cm
−1 2925, 1656;
1H NMR δH (CDCl3, 400 MHz) 7.33−7.40 (2H major rotamer, m),
7.25−7.29 (3H major rotamer, m), 7.16−7.25 (3H major rotamer +
6H minor rotamer, m), 7.07−7.14 (1H major rotamer + 2H minor
rotamer, m), 6.98 (1H minor rotamer, d, J = 7.5 Hz), 5.65 (1H minor
rotamer, d, J = 13.5 Hz), 5.50 (1H major rotamer, d, J = 13.5 Hz), 4.56
(1H minor rotamer, d, J = 13.5 Hz), 3.90 (1H major rotamer, d, J =
13.5 Hz), 2.75−2.89 (2H major rotamer, m), 2.52−2.20 (1H minor
rotamer, m), 2.35−2.45 (2H minor rotamer, m), 2.20−2.33 (2H major
rotamer + 6H minor rotamer, m), 1.97 (3H major rotamer, s), 1.89
(1H min, dd, J = 10.0, 2.5 Hz), 1.86 (3H major rotamer, s), 1.45 (3H
minor rotamer, s), 1.29 (3H major rotamer, s); 13C NMR δC (CDCl3,
100 MHz) data for mixture of rotamers, 172.0, 169.3, 137.4, 136.8,
136.4, 136.1, 135.9, 135.2, 132.9, 132.1, 131.7, 130.7, 130.2, 130.0,
128.2, 128.0, 127.9, 127.8, 127.7, 127.4, 127.3, 126.8, 126.6, 126.4,
123.0, 121.6, 60.3, 57.7, 54.0, 53.3, 34.2, 33.3, 32.9, 29.8, 29.4, 27.6,
27.3, 20.9, 19.3; MS m/z (ESI) found ([M]+Na) 420.0930,
C22H24BrNNaO requires 420.0933; HPLC (S,S)-Whelk-O1 (25 cm
× 4.6 mm) hexanes:iPrOH (1.0 mL/min) tR 11.70 and 12.66 min.
General Procedure for the Formation of Enamides 4b, 4d−i,
7a−d, 8a, 8b, 8d, 8e, 13b−d, 14, 15, 25a, 26a, 27a, 27b, 27d, 28
via Oximes, Method B. This procedure involved preparing
acetamides 5a−j or 2-chloroacetamides 5k−m via an iron-mediated
rearrangement37 of literature oximes.38,86−91 These acetamides were
then alkylated with alkyl halides to furnish the enamides 4b, 4d−i, 7a−
d, 8a, 8b, 8d, 8e, 13b−d, 14, 15, 25a, 26a, 27a, 27b, 27d, 28.
General Procedure for the Formation of Acetamides 5a−j. To
the oxime (1 equiv) was added acetic acid (3 equiv), acetic anhydride
(3 equiv), and iron powder (2 equiv) in anhydrous toluene. The
mixture was heated at 70 °C for 4−16 h, cooled to room temperature,
and filtered through Celite. Dichloromethane was added, and the
organic extracts were washed with 2 M NaOH (3 × 30 mL) and brine
(30 mL). The organic phase was dried over MgSO4, filtered, and then
concentrated in vacuo. Products were purified by column chromatog-
raphy or recrystallization as reported. (E)- And (Z)-N-(but-2-en-2-
yl)acetamide (5a, X = H, R1 = R2 = Me, R3 = H; 5b, X = H, R1 = R3 =
Me, R2 = H),34 N-(3-methylbut-2-en-2-yl)acetamide (5c, X = H, R1 =
R2 = R3 = Me),36 N-(2-methylprop-1-enyl)acetamide (5d, X = H, R1 =
H, R2 = R3 = Me),95 N-(1-phenyl-2-methylprop-1-en-1-yl)acetamide
(5e, X = H, R1 = Ph, R2 = R3 = Me),37 N-(2-methyl-3,4-
dihydronaphthalen-1-yl)acetamide (5g, X = H, R1 = R2 =
−C6H4CH2CH2−, R3 = Me),37 N-(cyclohexylidene(phenyl)methyl)-
acetamide [5h, X = H, R1 = Ph, R2 = R3 = −(CH2)4−],37 and N-(2-
phenylcyclohexene-1-yl)acetamide [5i, X = H, R1 = R2 = −(CH2)4−,
R3 = Ph]31 exhibited 1H and 13C NMR spectroscopic details identical
to those previously reported. They were purified by either column
chromatography or recrystallization as stated.
(E)-N-(But-2-en-2-yl)acetamide (5a, X = H, R1 = R3 = Me, R2 = H)
and (Z)-N-(But-2-en-2-yl)acetamide (5b, X = H, R1 = R2 = Me, R2 =
H).34 Conditions: butan-2-one oxime86 (3.00 g, 34.4 mmol), acetic
acid (5.91 mL, 103.0 mmol), acetic anhydride (9.74 mL, 103 mmol),
iron powder (3.84 g, 68.9 mmol), and anhydrous toluene (60 mL).
The crude product was used without further purification in the
preparation of 4b and 4d.
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N-(3-Methylbut-2-en-2-yl)acetamide (5c, X = H, R1 = R2 = R3 =
Me).36 Conditions: 3-methylbutan-2-one oxime87 (3.20 g, 31.6 mmol),
acetic acid (5.43 mL, 94.9 mmol), acetic anhydride (8.95 mL, 94.9
mmol), iron powder (3.53 g, 63.3 mmol), and anhydrous toluene (120
mL). The crude product was purified by recrystallization from
hexane:ethyl acetate 10:1. Yield 617 mg (15%).
N-(2-Methylprop-1-enyl)acetamide (5d, X = H, R1 = H, R2 = R3 =
Me).95 Conditions: isobutryaldehyde oxime88 (2.00 g, 22.9 mmol),
acetic acid (3.94 mL, 68.9 mmol), acetic anhydride (6.50 mL, 68.9
mmol), iron powder (2.56 g, 45.3 mmol), and anhydrous toluene (30
mL). The crude product was purified by column chromatography (pet.
ether:ethyl acetate 1:1). Yield 113 mg (4%).
N-(1-Phenyl-2-methylprop-1-en-1-yl)acetamide (5e, X = H, R1 =
Ph, R2 = R3 = Me).37 Conditions: 2-methyl-1-phenylpropan-1-one
oxime89 (4.93 g, 30.2 mmol), acetic acid (5.19 mL, 90.6 mmol), acetic
anhydride (8.55 mL, 90.6 mmol), iron powder (3.37 g, 60.4 mmol),
and anhydrous toluene (120 mL). The crude product was purified by
recrystallization from hexane:ethyl acetate 10:1. Yield 3.92 g (69%).
N-(2,4-Dimethylpent-2-en-3-yl)acetamide (5f, X = H, R1 = iPr, R2
= R3 = Me). Conditions: 2,4-dimethyl-3-pentanone oxime92 (4.72 g,
36.3 mmol), acetic acid (6.23 mL, 109 mmol), acetic anhydride (10.3
mL, 109 mmol), iron powder (4.06 g, 72.6 mmol), and anhydrous
toluene (120 mL). The crude product was purified by recrystallization
from hexane. Yield 3.17 g (56%); 5:3 ratio of isomers; white crystalline
solid; mp 64−66 °C; Rf 0.60 (pet. ether:EtOAc, 1:1); IR υmax (film)/
cm−1 3242, 2972, 1641; 1H NMR δH (CDCl3, 400 MHz) 6.15 (1H, s,
minor), 6.07 (1H, s, major), 2.90−2.98 (1H, m), 2.08 (3H, s, major),
1.88 (3H, s, minor), 1.77 (3H, s major and minor), 1.67 (3H, s,
minor), 1.61 (3H, s, major), 0.97 (6H, d, J = 7.0 Hz, minor), 0.95 (6H,
d, J = 7.0 Hz, major); 13C NMR δC (CDCl3, 75 MHz) 168.8, 131.3,
127.7, 29.7, 29.3, 23.4, 20.6, 20.6, 20.1, 19.9, 19.6, 19.3, 19.3; MS m/z
(ESI) found ([M]+Na) 178.1202, C9H17NNaO requires 178.1202.
N-(2-Methyl-3,4-dihydronaphthalen-1-yl)acetamide (5g, X = H,
R1 = R2 = −C6H4CH2CH2−, R3 = Me).
37 Conditions: 2-methyl-1-
tetralone oxime88 (980 mg, 5.6 mmol), acetic acid (0.97 mL, 16.8
mmol), acetic anhydride (0.62 mL, 16.8 mmol), iron powder (0.63 g,
72.6 mmol), and anhydrous toluene (20 mL). The crude product was
purified flash chromatography (5:1 hexane:EtOAc). Yield 403 mg
(36%).
N-(Cyclohexylidene(phenyl)methyl)acetamide [5h, X = H, R1 =
Ph, R2 = R3 = −(CH2)4−].31,37 Conditions: cyclohexyl(phenyl)-
methanone oxime88 (1.60 g, 7.87 mmol), acetic acid (1.35 mL, 23.6
mmol), acetic anhydride (2.23 mL, 23.6 mmol), iron powder (879 mg,
15.7 mmol), and anhydrous toluene (12 mL). The crude product was
purified by recrystallization from petroleum ether:ethyl acetate 10:1.
Yield 877 mg (49%).
N-(2-Phenylcyclohexene-1-yl)acetamide [5i, X = H, R1 = R2 =
−(CH2)4−, R3 = Ph].35 Conditions: 2-phenylcyclohexanone oxime90
(3.00 g, 15.8 mmol), acetic acid (2.72 mL, 47.6 mmol), acetic
anhydride (4.49 mL, 47.6 mmol), iron powder (1.77 g, 31.7 mmol),
and anhydrous toluene (25 mL). The crude product was purified by
column chromatography (pet. ether:EtOAc, 6:1). Yield 640 mg (19%).
N-(2,2,6-Trimethylcyclohexen-1-yl)acetamide [5j, X = H, R1 = R2
= −CMe2(CH2)3−, R3 = Me]. Conditions: 2,2,6-trimethylcyclohex-
anone oxime91 (2.40 g, 15.5 mmol), acetic acid (2.65 mL, 46.4 mmol),
acetic anhydride (4.38 mL, 46.4 mmol), iron powder (1.73 g, 30.9
mmol), and anhydrous toluene (25 mL). The crude product was
purified by gradient column chromatography (pet. ether:EtOAc, 9:1 to
1:1). Yield 403 mg (14%); 2:1 ratio isomers; yellow solid; mp 122−
124 °C; Rf 0.50 (pet. ether:EtOAc, 1:1); IR υmax (film)/cm
−1 3271,
2926, 1649; 1H NMR δH (CDCl3, 400 MHz) 6.11 (1H, s, minor), 6.12
(1H, s, major), 2.07 (2H, s), 2.03−2.09 (2H, m), 1.89 (1H, s), 1.62
(1H, s), 1.48−1.68 (4H, m), 1.54 (2H, s), 1.01 (2H, s), 1.00 (4H, s);
13C NMR δC (100 MHz, CDCl3) mixture of rotamers, 173.7, 168.4,
134.5, 131.9, 131.6, 130.4, 38.9, 38.8, 35.6, 35.1, 32.0, 31.8, 27.4, 27.2,
27.1, 26.5, 23.4, 19.6, 19.4, 19.3, 19.1, 19.0; MS m/z (ESI) 204.1
([M]+Na) [found ([M]+Na) 204.1366, C11H19NNaO requires
204.1364].
General Procedure for the Formation of 2-Chloroaceta-
mides. 2-Chloroacetamides were prepared by the method of Tang et
al.33 using the following modification: Oxime (1 equiv), 2-chloroacetic
acid (3 equiv), 2-chloroacetic anhydride (3 equiv) and iron powder (2
equiv) were heated to reflux in anhydrous toluene under an inert
atmosphere for 6−16 h. The mixture was then filtered through Celite,
diluted with DCM and washed with 2 M NaOH and saturated NaCl
solution. The organic phase was then dried over MgSO4, filtered and
then concentrated in vacuo to give the crude product. Products were
purified by column chromatography or recrystallization as stated
below.
N-(2-Methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide
(5k, X = Cl, R1 = R2 = −C6H4CH2CH2−, R3 = Me). Conditions: 2-
methyl-1-tetralone oxime89 (2.94 g, 16.8 mmol, 1 equiv), 2-
chloroacetic acid (4.76 g, 50.4 mmol, 3 equiv), 2-chloroacetic
anhydride (8.61 g, 50.4 mmol, 3 equiv), and iron powder (1.88 g,
33.6 mmol, 2 equiv) were heated to 70 °C for 36 h in anhydrous
toluene (25 mL). The crude product was then purified by
recrystallization from hexane:EtOAc 10:1 to give the 2.09 g, (53%);
pale brown solid; mp 139−141 °C; Rf 0.23 (pet. ether:EtOAc, 3:1); IR
υmax (film)/cm
−1 3229, 2933, 1650; 1H NMR δH (CDCl3, 400 MHz)
7.59 (1H, s), 7.22−7.09 (3H, m), 7.06 (1H, d, J = 7.5), 4.25 (2H, s),
2.84 (2H, t, J = 8.0), 2.42 (2H, t, J = 8.0), 1.88 (3H, s); 13C NMR δC
(CDCl3, 100 MHz) 164.8, 135.3, 135.0, 132.5, 127.6, 127.0, 126.6,
125.2, 121.3, 42.9, 29.8, 27.6, 19.6; MS m/z (ESI) 258 ([M]+Na)
[found ([M]+Na) 258.0656, C13H14ClNNaO requires 258.0656].
Anal. Found: C, 66.2%; H, 5.9%; N, 5.8% C13H14ClNO. Calcd: 66.2%;
H, 6.0%; N, 5.8%.
2-Chloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide (5l, X = Cl,
R1 = Ph, R2 = R3 = Me).96 Conditions: 2-methyl-1-phenylpropan-1-one
oxime38 (2.00 g, 12.2 mmol), 2-chloroacetic acid (3.47 g, 36.8 mmol),
2-chloroacetic anhydride (6.28 g, 36.8 mmol), iron powder (1.37 g,
24.5 mmol), and anhydrous toluene (20 mL). The crude product was
purified by recrystallization (pet. ether:EtOAc, 6:1) to give 676 mg,
(25%).
2-Chloro-N-(cyclohexylidene(phenyl)methyl)acetamide (5m, X =
Cl, R1 = Ph, R2 = R3 = −(CH2)4−). Conditions: cyclohexyl(phenyl)-
methanone oxime89 (4.00 g, 19.7 mmol), 2-chloroacetic acid (5.58 g,
59.1 mmol), 2-chloroacetic anhydride (10.1 g, 59.1 mmol), iron
powder (2.20 g, 39.4 mmol), and anhydrous toluene (80 mL). The
crude product was purified by column chromatography (pet.
ether:EtOAc, 4:1) to give 2.26 g (48%); yellow crystalline solid; mp
128−130 °C; Rf 0.64 (pet. ether:EtOAc, 1:1); IR υmax(film)/cm−1
3232, 2917, 1654; 1H NMR δH (CDCl3, 400 MHz) 7.61 (1H, s),
7.12−7.39 (5H, m), 4.08 (2H, s), 2.17−2.26 (4H, m), 1.51−1.69 (6H,
m); 13C NMR δC (CDCl3, 100 MHz) 164.2, 138.4, 137.9, 129.2,
128.3, 127.6, 124.1, 42.8, 31.0, 30.8, 28.0, 27.4, 26.5; MS m/z (ESI)
found ([M]+Na) 286.0977, C15H18ClNNaO requires 286.0969.
General Procedure for the Formation of Enamides (4b, 4d−
i, 7a−d, 8a, 8b, 8d, 8e, 13b−d, 14, 15, 25a, 26a, 27a, 27b, 27d,
28). The acetamide 5a−j or 2-chloroacetamide 5k−m (1 equiv) was
added to sodium hydride (1.5−5.0 equiv, 60% w/w dispersion in
mineral oil) in anhydrous THF and cooled to 0 °C. Benzyl bromide
(1.05−1.5 equiv) was then added and the reaction heated to reflux
under an inert atmosphere for 10−16 h. The reaction mixture was
then added to water (20 mL) and extracted with ethyl acetate or DCM
(3 × 50 mL). The combined organic layers were then dried over
MgSO4, filtered, and then concentrated in vacuo to give the crude
product. Products were purified by column chromatography or
recrystallization as stated below.
(E)-N-Benzyl-N-(but-2-en-2-yl)acetamide (4d) and (Z)-N-Benzyl-
N-(but-2-en-2-yl)acetamide (4b). Conditions: N-(but-2-en-2-yl)-
acetamide (200 mg, 1.77 mmol), sodium hydride (354 mg, 8.84
mmol), benzyl bromide (0.22 mL, 1.86 mmol), and anhydrous THF
(25 mL). Yield 2:1 (Z:E) ratio of isomers 4d:4b. Purification by
column chromatography (pet. ether:EtOAc, 6:1) gave a pure sample of
(Z)-N-benzyl-N-(but-2-en-2-yl)acetamide (4d) as a yellow oil (57 mg,
16%) and an impure sample of (E)-N-benzyl-N-(but-2-en-2-yl)-
acetamide (4b) as a 1:1.8 (Z:E) mixture (153 mg).
Data for 4b: Rf 0.1 (pet. ether:EtOAc, 6:1); IR υmax (film)/cm
−1
2934, 1655; 1H NMR δH (CDCl3, 400 MHz) 7.08−7.34 (5H, m), 5.30
(1H, q, J = 7.0 Hz), 4.72 (1H, d, J = 14.0 Hz), 4.32 (1H, d, J = 14.0
Hz), 1.93 (3H, s), 1.67 (3H, s), 1.11 (3H, d, J = 7.0 Hz); 13C NMR δC
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(CDCl3, 100 MHz) 169.7, 137.7, 136.3, 129.3, 128.2, 127.4, 124.2,
48.5, 21.3, 21.1, 12.6; MS m/z (ESI) found ([M]+Na) 204.1383,
C13H18NO requires 204.1383.
Data for 4d: discernible data Rf 0.075 (pet. ether:EtOAc, 6:1); IR
υmax (film)/cm
−1 (mixture) 2934, 1655; 1H NMR δH (CDCl3, 400
MHz) δ 7.09−7.45 (5H, m), 5.11 (1H, q, J = 7.0 Hz), 4.53 (2H, s),
1.97 (3H, s), 1.64 (3H, s), 1.50 (3H, d, J = 7.0 Hz); 13C NMR δC
(CDCl3, 100 MHz) δ 170.0, 138.1, 137.3, 128.7, 127.1, 126.4, 125.9,
49.4, 21.7, 15.7, 13.2; MS m/z (ESI) found ([M]+Na) 204.1383,
C13H18NO requires 204.1383.
N-Benzyl-N-(2-methylprop-1-enyl)acetamide (4e).97 Conditions:
N-(2-methylprop-2-en-2-yl)acetamide (200 mg, 1.77 mmol), sodium
hydride (354 mg, 8.84 mmol), benzyl bromide (0.22 mL, 1.86 mmol),
and anhydrous THF (25 mL). Yield 99 mg (28%); colorless oil; Rf
0.35 (pet. ether:EtOAc, 4:1); IR υmax (film)/cm
−1 2914, 1647; 1H
NMR δH (CDCl3, 400 MHz) 7.11−7.37 (5H, m), 5.74 (1H, apparent
quintet, J = 1.0 Hz), 4.56 (2H, s), 1.97 (3H, s), 1.65 (3H, d, J = 1.0
Hz), 1.39 (3H, d, J = 1.0 Hz); 13C NMR δC (CDCl3, 100 MHz) 170.9,
137.5, 136.5, 128.9, 128.4, 127.3, 124.0, 50.7, 22.1, 21.9, 17.5; MS m/z
ESI 204.1 ([M]+H), 226.1 ([M]+Na).
N-Benzyl-N-(2-phenylcyclohexene-1-yl)acetamide (4f).98 Condi-
tions: N-benzyl-N-(2-phenylcyclo-hexene-1-yl)acetamide (300 mg,
1.39 mmol), sodium hydride (279 mg, 6.97 mmol), benzyl bromide
(0.17 mL, 1.46 mmol), and anhydrous THF (30 mL). Crude product
was purified by column chromatography (pet. ether:EtOAc 2:1). Yield
293 mg (69%); yellow oil; Rf 0.48 (pet. ether:EtOAc, 2:1); IR υmax
(film)/cm−1 2928, 1638; δH (CDCl3, 400 MHz) 7.09−7.31 (10H, m),
5.10 (1H, d, J = 14.5 Hz), 3.50 (1H, d, J = 14.5 Hz), 2.34−2.41 (2H,
m), 2.09 (3H, s), 1.94−2.07 (2H, m), 1.57−1.79 (4H, m); 13C NMR
δC (CDCl3, 100 MHz) 170.2, 140.7, 138.3, 136.3, 135.6, 128.9, 128.7,
128.4, 127.4, 127.3, 127.1, 50.6, 31.8, 31.4, 23.1, 22.7, 22.2; MS m/z
(ESI) 306.1 [M + H]+, 328.1 [M + Na]+; HPLC (S,S)-Whelk-O1 (25
cm × 4.6 mm) hexanes iPrOH (1.0 mL/min) tR 27.55 min.
N-Benzyl-N-(3-methylbut-2-en-2-yl)acetamide (4g). Conditions:
N-(3-methylbut-2-en-2-yl)acetamide (500 mg, 3.93 mmol), sodium
hydride (786 mg, 19.66 mmol), benzyl bromide (0.49 mL, 4.13
mmol), and anhydrous THF (60 mL). Yield 680 mg (80%); yellow
oil; Rf 0.33 (pet. ether:EtOAc, 4:1); IR υmax (film)/cm
−1 2920, 1644;
1H NMR δH (CDCl3, 400 MHz) 7.23−7.31 (5H, m), 4.64 (1H, d, J =
14.0 Hz), 4.50 (1H, d, J = 14.0 Hz), 1.95 (3H, s), 1.69 (3H, s), 1.64
(3H, s), 1.27 (3H, s); 13C NMR δC (CDCl3, 375 MHz) 170.2, 137.9,
131.1, 129.6, 129.5, 128.3, 127.4, 49.2, 21.4, 19.6, 19.4, 17.5; MS m/z
(ESI) found ([M]+H) 218.1540, C14H20NO requires 218.1539.
N-Methyl-N-(2,4-dimethylpent-2-en-3-yl)acetamide (4h). Condi-
tions: N-(2,4-dimethylpent-2-en-3-yl)acetamide (496 mg, 3.2 mmol),
sodium hydride (1.02g, 25.6 mmol), and methyl iodide (3.64 g, 25.6
mmol). Yield 186 mg (33%); colorless oil; Rf 0.16 (3:1 pet.
ether:EtOAc); IR υmax (cm
−1) 2965, 1637; 1H NMR δH (CDCl3,
300 MHz) 3.05−2.91 (1H, sept, J = 6.9 Hz), 2.96 (3H, s), 1.91 (3H,
s), 1.73 (3H, s), 1.55 (3H, s), 1.08 (3H, d, J = 6.9 Hz), 0.97 (3H, d, J =
6.9 Hz); 13C NMR δC (CDCl3, 75 MHz) 171.6, 140.5, 129.5, 36.3,
30.3, 22.9, 21.3, 20.0, 19.8, 19.3; MS m/z (ESI) 192 ([M]+Na), 170
([M]+H) [found ([M]+H) 170.1541, C10H20NO requires 170.1545];
HPLC (S,S)-Whelk-O1 (25 cm × 4.6 mm) hexanes:iPrOH (1.0 mL/
min) tR 43.67 and 45.73 min; Anal. Found C, 69.6%; H, 11.2%; N,
7.9% C10H20NO. Calcd 71.0%; H, 11.3%; N, 8.3%.
N-Benzyl-N-(2,4-dimethylpent-2-en-3-yl)acetamide (4i). Condi-
tions: N-(2,4-dimethylpent-2-en-3-yl)acetamide (149 mg, 0.96
mmol), sodium hydride (192 mg, 4.8 mmol), and benzyl bromide
(120 mg, 1.01 mmol). Yield 52 mg (22%); colorless oil; Rf 0.36 (3:1
pet. ether:EtOAc); IR υmax/cm
−1 2965, 1642; 1H NMR δH (CDCl3,
300 MHz) 7.40−7.27 (5H, m), 5.27 (1H, d, J = 14.0 Hz), 3.99 (1H, d,
J = 14.0 Hz), 2.98 (1H, sept, J = 7.3 Hz), 1.99 (3H, s), 1.7 (3H, s),
1.27 (3H, d, J = 7.5 Hz), 1.05 (3H, d, J = 7.5 Hz), 1.01 (3H, s); 13C
NMR δC (CDCl3, 75 MHz) 170.2, 137.6, 131.7, 130.0, 128.3, 127.4,
50.7, 30.1, 23.9, 21.7, 20.5, 19.5, 19.4; MS m/z (ESI) found ([M]+Na)
268.1672, C16H23NNaO requires 268.1677; HPLC (S,S)-Whelk-O1
(25 cm × 4.6 mm) hexanes:iPrOH (1.0 mL/min) tR 30.07 and 37.30
min.
N-Benzyl-N-(1-phenyl-2-methylprop-1-en-1-yl)acetamide (7a).38
Conditions: N-(1-phenyl-2-methylprop-1-en-1-yl)acetamide (3.50 g,
18.5 mmol), sodium hydride (3.70 mg, 92.5 mmol), benzyl bromide
(2.30 mL, 19.4 mmol), and anhydrous THF (300 mL). Yield 3.67 g
(71%); yellow oil; Rf 0.18 (pet. ether:EtOAc, 6:1); IR υmax (film)/cm
−1
2991, 1642; 1H NMR δH (CDCl3, 400 MHz) 7.28−7.42 (3H, m),
7.19−7.28 (7H, m), 5.27 (1H, d, J 14.0 Hz), 3.48 (1H, d, J = 14.0 Hz),
2.16 (3H, s), 1.76 (3H, s), 1.28 (3H, s); 13C NMR δC (CDCl3, 75
MHz) 170.8, 137.3, 136.6, 133.8, 133.5, 129.9, 129.4, 128.4, 128.2,
127.9, 127.4, 48.5, 21.5, 21.4, 20.9; MS m/z (ESI) 280.2 ([M]+Na);
HPLC (S,S)-Whelk-O1 (25 cm × 4.6 mm) hexanes:iPrOH (1.0 mL/
min) tR 13.70 min.
N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)acetamide
(7b). Conditions: N-(2-methyl-3,4-dihydronaphthalen-1-yl)acetamide
(141 mg, 0.70 mmol), sodium hydride (140 mg, 3.5 mmol), benzyl
bromide (0.09 mL, 0.74 mmol), and anhydrous THF (10 mL). Yield
99 mg (49%); white solid; mp 158−159 °C; Rf 0.36 (pet. ether:EtOAc,
3:1); IR υmax (film)/cm
−1 2927, 1643; 1H NMR δH (CDCl3, 400
MHz) 7.30−7.17 (8H, m), 6.98 (1H, m), 5.49 (1H, d, J = 13.5 Hz),
3.74 (1H, d, J = 13.5 Hz), 2.87−2.69 (2H, m), 2.35 (1H, ddd, J = 16.5,
6.5, 4.0 Hz), 2.14 (1H, ddd, J = 16.6, 6.5, 4.0 Hz), 1.90 (3H, s), 1.24
(3H, brs); 13C NMR δC (CDCl3, 75 MHz) 170.6,136.5, 136.2, 135.6,
135.5, 131.2, 129.6, 127.5, 127.1, 126.8, 126.6, 126.3, 121.2, 48.8, 28.9,
26.8, 20.6, 18.3; MS m/z (ESI) 314 ([M]+Na) [found ([M]+H)
292.1696, C20H22NO requires 292.1701]; HPLC (S,S)-Whelk-O1 (25
cm × 4.6 mm) hexanes:iPrOH (1.0 mL/min) tR 30.07 and 37.38 min.
N-Benzyl-N-(2,2,6-trimethylcyclohexen-1-yl)acetamide (7c). Con-
ditions: N-(2,2,6-trimethylcyclo-hexen-1-yl)acetamide (300 mg, 1.65
mmol), sodium hydride (331 mg, 8.27 mmol), benzyl bromide (0.21
mL, 1.73 mmol), and anhydrous THF (30 mL). Yield 0.331 g (74%)
colorless oil; Rf 0.52 (pet. ether:EtOAc, 3:1); IR υmax (film)/cm
−1
2931, 1641; 1H NMR δH (CDCl3, 400 MHz) 7.22−7.35 (5H, m), 5.00
(1H, d, J = 14.5 Hz), 4.35 (1H, d, J = 14.5 Hz), 1.99−2.07 (2H, m),
1.97 (3H, s), 1.50−1.83 (4H, m), 1.17 (3H, s), 1.07 (3H, s), 1.06 (3H,
s); 13C NMR δC (CDCl3, 100 MHz) 172.2, 139.5, 138.0, 133.9, 129.5,
128.2, 127.2, 51.7, 41.2, 36.0, 31.8, 30.5, 27.7, 21.9, 19.4 18.6; MS m/z
(ESI) found ([M]+HNa) 294.1829, C18H25NNaO requires 294.1828.
N-Benzyl-N-(cyclohexylidene(phenyl)methyl)acetamide (7d).
Conditions: N-(cyclohexylidene(phenyl)methyl)acetamide (600 mg,
2.62 mmol), sodium hydride (520 mg, 13.1 mmol), benzyl bromide
(0.33 mL, 2.75 mmol), and anhydrous THF (50 mL). The crude
product was recrystallized from hexane to give 0.721 g (86%); pale
orange solid; mp 89−92 °C; Rf 0.45 (pet. ether:EtOAc, 4:1); IR υmax
(film)/cm−1 2925, 1646; 1H NMR δH (CDCl3, 400 MHz) 7.23−7.40
(10H, m), 5.37 (1H, d, J = 14.0 Hz), 3.37 (1H, d, J = 14.0 Hz), 2.38−
2.54 (1H, m), 2.18 (3H, s), 1.77−1.94 (2H, m), 1.60−1.74 (2H, m),
1.43−1.54 (1H, m), 1.22−1.42 (3H, m), 0.42−0.56 (1H, m); 13C
NMR δC (CDCl3, 100 MHz) 170.8, 140.8, 137.4, 136.5, 130.7, 130.0,
129.3, 128.5, 128.3, 128.0, 127.4, 48.0, 31.4, 31.3, 28.0, 26.7, 26.4, 21.5;
MS m/z (ESI) found ([M]+H) 320.2005, C22H26NO requires
320.2009; HPLC (S,S)-Whelk-O1 (25 cm × 4.6 mm) hexanes:iPrOH
(1.0 mL/min) tR 24.10 min.
N-(1-Cyclohexenyl)-N-methylphenylacetamide (8a). Conditions:
N-(1-cyclohexenyl)phenylacetamide39 (58 mg, 0.27 mmol), NaH (9.5
mg, 0.40 mmol), MeI (57 mg, 25 μL) at rt for 5 h, purified by column
chromatography (4:1 pet. ether:EtOAc). Yield 48 mg (84%); Rf (4:1
pet. ether:EtOAc) 0.23; IR υmax (film)/cm
−1 2926, 1648, 1378, 1102;
1H NMR δH (CDCl3, 300 MHz) 7.34−6.98 (5H, m), 5.54 (1H, s),
3.65 (2H, s), 2.97 (3H, s), 2.18−2.05 (2H, m), 1.99−1.93 (2H, m),
1.75−1.62 (4H, m); 13C NMR δC (CDCl3, 75.5 MHz) 170.7, 140.4,
136.3, 129.1, 128.4, 126.8, 126.6, 40.7, 34.3, 27.6, 24.7, 22.7, 21.6; MS
m/z (ESI) 252 ([M]+Na) [found ([M]+Na) 252.1361, C15H19NNaO
requires 252.1364].
N-(1-Cyclohexenyl)-N-butylphenylacetamide (8b). Conditions: N-
(1-cyclohexenyl)phenylacetamide39 (65 mg, 0.30 mmol), NaH (10.8
mg, 0.45 mmol), and 1-bromobutane (62 mg, 0.467 mmol, 49 μL).
Yield 66 mg (70%); Rf (4:1 pet. ether:EtOAc) 0.45; IR υmax (film)/
cm−1 2930, 1640, 1400, 1126; 1H NMR δH (CDCl3, 300 MHz) 7.42−
7.07 (5H, m), 5.47 (1H, m), 3.63 (2H, s), 3.36 (2H, br s), 2.15−1.84
(4H, m, 4H), 1.77−1.51 (4H, m), 1.51−1.28 (m, 2H), 1.41−1.14 (2H,
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m), 1.03 (3H, t, J 7.5 Hz); 13C NMR δC (CDCl3, 75.5 MHz) 170.3,
138.6, 136.5, 129.1, 128.4, 128.0, 126.5, 45.4, 41.1, 30.2, 28.0, 24.9,
22.9, 21.7, 20.2, 14.0; MS m/z (ESI) 294 ([M]+Na) [found ([M]+Na)
294.1831, C18H25NNaO requires 294.1834].
N-(1-Cyclohexenyl)-N-isopropylphenylacetamide (8d). Condi-
tions: N-(1-cyclohexenyl)phenylacetamide39 (66 mg, 0.31 mmol),
NaH (11.3 mg, 0.47 mmol), and 2-bromopropane (58 mg, 0.47 mmol,
44 μL). Yield 12 mg (13%); Rf (3:1 pet. ether:EtOAc) 0.66; IR υmax
(film)/cm−1 2929, 1642, 1391, 1229; 1H NMR δH (CDCl3, 300 MHz)
7.36−7.14 (5H, m), 5.40 (1H, s), 4.59 (1H, sep, J 7.5 Hz), 3.57 (2H,
s), 2.20−1.48 (8H, m), 1.19−1.00 (6H, m); 13C NMR δC (CDCl3,
75.5 MHz) 170.3, 136.7, 136.3, 130.1, 129.1, 128.4, 126.5, 46.6, 41.8,
31.7, 25.1, 23.1, 21.6, 21.1; MS m/z (ESI) 280 ([M]+Na) [found
([M]+Na) 280.1677, C17H23NNaO requires 280.1677].
N-(1-Cyclohexenyl)-N-t-butyldimethylsilylphenylacetamide (8e).
This was prepared in an NMR tube by the reaction of N-(1-
cyclohexenyl)phenylacetamide43 (43 mg, 0.2 mmol) with 2 equiv of
2,6-lutidine (42.8 mg, 46.5 μL, 0.4 mmol) and tert-butyldimethylsilyl
triflate (106 mg, 92 μL, 0.4 mmol) in 1 mL of toluene-d8. The crude
mixture was submitted to VT 1H NMR immediately without
purification.
N-Cyclohex-1-enyl-N-2-fluorobenzylacetamide (13b). Yield 45%;
clear oil; Rf (3:1 pet. ether:EtOAc) 0.45; IR υmax (film)/cm
−1 2932,
1648, 1489; 1H NMR δH (CDCl3, 300 MHz) 7.40−7.31 (1H, m),
7.25−7.13 (1H, m), 7.06 (1H, t, J = 7.4 Hz), 6.97 (1H, t, J = 9.0 Hz),
5.36 (1H, s), 4.69 (2H, s), 2.05 (3H, s), 2.04−1.92 (4H, m), 1.72−
1.59 (2H, m), 1.59−1.43 (2H, m); 13C NMR δC (CDCl3, 75.5 MHz)
170.3, 161.0 (d, J = 244.5 Hz), 138.8, 131.2 (d, J 3.8 Hz), 129.0 (d, J =
8.25 Hz), 128.1, 124.9 (d, J = 14.25 Hz), 124.1 (d, J = 3.8 Hz), 115.0
(d, J = 21.8 Hz), 42.3 (d, J = 3.7 Hz), 27.9, 24.9, 22.8, 21.7, 21.5; MS
m/z (ESI) 270 ([M]+Na) [found ([M]+Na) 270.1263, C15H18FNNaO
requires 270.1270].
N-Cyclohex-1-enyl-N-2-iodobenzylacetamide (13c). Yield 45%;
yellow oil; Rf (6:1 pet. ether:EtOAc) 0.49; IR υmax (film)/cm
−1 2928,
1643; 1H NMR δH (CDCl3, 300 MHz) 7.78 (1H, d, J = 8.0 Hz), 7.37
(1H, d, J = 8.0 Hz), 7.29 (1H, t, J = 8.0 Hz), 6.93 (1H, t, J = 8.0 Hz),
5.44 (1H, s), 4.73 (2H, s), 2.10 (3H, s), 2.02 (4H, m), 1.70−1.62 (2H,
m), 1.57−1.52 (2H, m); 13C NMR δC (101 MHz, CDCl3) 170.3,
140.3, 139.2, 138.6, 129.7, 128.8, 128.4, 99.6, 53.5, 28.1, 24.8, 22.7,
21.5, 21.4; MS m/z (ESI) 356.05 ([M]+H) [found ([M]+H) 356.0516,
C15H19INO requires 356.0506].
N-Cyclohex-1-enyl-N-2,6-difluorobenzylacetamide (13d). Yield
45%; colorless oil; Rf (3:1 pet. ether:EtOAc) 0.45; IR υmax (film)/
cm−1 2933, 1651, 1470, 1387; 1H NMR δH (CDCl3, 300 MHz) 7.24−
7.13 (1H, m), 6.96−6.72 (2H, m), 5.27 (1H, s), 4.78 (2H, s), 1.99
(3H, s), 1.96−1.83 (4H, m), 1.63−1.48 (2H, m), 1.48−1.35 (2H, m);
13C NMR δC (CDCl3, 75.5 MHz) 169.4, 162.0 (dd, J = 255.8, 7.5 Hz),
137.4, 129.5 (t, J = 10.5 Hz), 128.7, 113.0 (t, J = 18.8 Hz), 111.1 (dd, J
= 17.3, 7.5 Hz), 35.6 (t, J = 3.0 Hz), 27.4, 24.9, 22.8, 21.7, 21.4; MS m/
z (ESI) 288 ([M]+Na) [found ([M]+Na) 288.1170, C15H17F2NNaO
requires 288.1176].
N-Cyclohex-1-enyl-N-2,6-dichlorobenzylacetamide (13e). Yield
85%; yellow oil; Rf (4:1 pet. ether:EtOAc) 0.28; IR υmax (film)/cm
−1
2929, 1647; 1H NMR δH (CDCl3, 300 MHz) 7.28 (2H, d, J = 7.0 Hz),
7.14 (1H, t, J = 7.0 Hz), 5.30−5.32 (1H, m), 5.06 (2H, br s), 2.05
(3H, s), 1.95−1.78 (4H, m), 1.56−1.48 (2H, m), 1.45−1.34 (2H, m);
13C NMR δC (CDCl3, 75.5 MHz) 169.7, 137.4, 137.2, 133.1, 129.4,
129.2, 128.4, 43.5, 28.4, 24.9, 22.8, 21.5, 21.4; MS m/z (ESI) 320




26%; yellow oil; Rf (6:1 pet. ether:EtOAc) 0.47; IR υmax (film)/cm
−1
2926, 1648; 1H NMR δH (CDCl3, 300 MHz) 7.48 (2H, d, J = 8.0 Hz),
6.95 (1H, t, J = 8.0 Hz), 5.35 (1H, s), 5.06 (2H, s), 2.02 (3H, s), 1.88−
1.84 (4H, m), 1.53−1.47 (2H, m), 1.42−1.36 (2H, m); 13C NMR δC
(101 MHz, CDCl3) 169.9, 137.3, 135.7, 132.5, 130.2, 129.5, 127.1,
48.8, 28.7, 24.9, 22.8, 21.4, 21.3; MS m/z (ESI) 385.98 ([M]+H)
[found ([M]+H) 385.9747, C15H18Br2NO requires 385.9750].
N-(2-Bromobenzyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide
(14). Conditions: N-(1-phenyl-2-methylprop-1-en-1-yl)acetamide37
(9e) (1.82 g), sodium hydride (1.92 g, 48.1 mmol), and 2-
bromobenzyl bromide (2.52 g, 10.1 mmol) in anhydrous THF (140
mL). The crude product was purified by column chromatography (pet.
ether:EtOAc, 4:1). Yield 1.88 g (55%); pale yellow crystalline solid;
mp 92−94 °C; Rf 0.43 (pet. ether:EtOAc, 4:1); IR υmax (film)/cm−1
2922, 1640; 1H NMR δH (CDCl3, 400 MHz) 7.53 (1H, d, J = 7.5 Hz),
7.46 (1H, d, J = 8.0 Hz), 7.25−7.40 (5H, m), 7.21 (1H, t, J = 7.5 Hz),
7.08 (1H, t, J = 7.5 Hz), 5.22 (1H, d, J = 14.5 Hz), 4.13 (1H, d, J =
14.5 Hz), 2.21 (3H, s), 1.82 (3H, s), 1.51 (3H, s); 13C NMR δC
(CDCl3, 100 MHz) 171.4, 137.1, 136.5, 134.2, 132.7, 132.6, 129.4,
129.2, 129.0, 128.2, 127.8, 127.3, 124.4, 48.7, 21.5, 21.5, 21.1; MS m/z
(ESI) 358 ([M]+H) [found ([M]+H) 358.0800, C19H21BrNO requires
358.0801].
N-Cyclohept-1-enyl-N-2,6-dibromobenzylacetamide (15). Yield
49%; yellow oil; Rf (6:1 pet. ether:EtOAc) 0.45; IR υmax (film)/cm
−1
2921, 1647; 1H NMR δH (400 MHz, CDCl3) 7.49 (2H, d, J = 8.0 Hz),
6.97 (1H, t, J = 8.0 Hz), 5.72 (1H, t, J = 6.2 Hz), 5.12 (1H, br s), 5.00
(1H, br s), 2.03 (3H, s), 1.95 (4H, m), 1.52−1.32 (6H, m); 13C NMR
δC (101 MHz, CDCl3) 169.7, 142.3, 135.5, 133.4, 132.5, 130.2, 127.1,
49.7, 34.5, 30.8, 27.0, 26.2, 25.4, 21.9; MS m/z (ESI) 399.99 ([M]+H)
[found ([M]+H) 399.9909, C16H20Br2NO requires 399.9906].
N-Benzyl-2-chloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide
(25a). The general procedure for the alkylation of enamides (6.1.4)
was applied using 2-chloro-N-(2-methyl-1-phenylprop-1-enyl)-
acetamide (500 mg, 2.24 mmol), sodium hydride (447 mg, 11.2
mmol), and benzyl bromide (278 μL, 2.35 mmol) in anhydrous THF
(40 mL). Yield 316 mg (42%); yellow oil; Rf 0.28 (pet. ether:EtOAc,
6:1); IR υmax (film)/cm
−1 2933, 1659; 1H NMR δH (CDCl3, 400
MHz) 7.30−7.43 (3H, m), 7.22−7.30 (7H, m), 5.25 (1H, d, J = 14.0
Hz), 4.36 (1H, d, J = 13.5 Hz), 4.12 (1H, d, J = 13.5 Hz), 3.61 (1H, d,
J = 14.0 Hz), 1.81 (3H, s), 1.30 (3H, s); 13C NMR δC (CDCl3, 75
MHz) 166.6, 136.4, 135.7, 135.2, 132.6, 139.0, 129.5, 128.7, 128.4,




oacetamide (1.9 g, 8.06 mmol), sodium hydride (1.61 g, 40.3 mmol),
benzyl bromide (1.01 mL, 8.46 mmol), and anhydrous THF (150
mL). Yield 1.1 g (46%); white solid; mp 111−113 °C; Rf 0.4 (pet.
ether:EtOAc, 9:1); IR υmax (film)/cm
−1 2928, 1663; 1H NMR δH
(CDCl3, 400 MHz) 7.24−7.41 (4H, m), 5.34 (1H, d, J = 14.0 Hz),
4.39 (1H, d, J = 13.5 Hz), 4.13 (1H, d, J = 13.5 Hz), 3.48 (1H, d, J =
14.0 Hz), 2.45−2.51 (1H, m), 1.75−1.87 (1H, m), 1.64−1.74 (1H,
m), 1.49−1.62 (2H, m), 1.35−1.44 (1H, m), 1.09−1.36 (3H, m),
0.51−0.48 (1H, m); 13C NMR δC (CDCl3, 100 MHz) 166.5, 142.0,
136.4, 135.5, 130.1, 129.8, 129.5, 129.3, 128.6, 128.3, 127.7, 49.0, 41.8,
31.4, 31.3, 27.9, 26.7, 26.2; MS m/z (ESI) found ([M]+Na) 376.1435,
C22H24ClNNaO requires 376.1439; HPLC (S,S)-Whelk-O1 (25 cm ×
4.6 mm) hexanes:iPrOH (1.0 mL/min) partially resolved, tR 23.50 and
27.75 min.
N-Benzyl-2-chloro-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-
acetamide (27a). Conditions: N-(2-methyl-3,4-dihydronaphthalen-1-
yl)-2-chloroacetamide (1.9 g, 8.06 mmol), sodium hydride (1.61 g,
40.3 mmol), benzyl bromide (1.01 mL, 8.46 mmol), and anhydrous
THF (150 mL). Yield 960 mg (37%); white solid; mp 99−101 °C; Rf
0.18 (pet. ether:EtOAc, 9:1); IR υmax (film)/cm
−1 2925, 1666; 1H
NMR δH (CDCl3, 400 MHz) 7.09−7.42 (8H, m), 6.95 (1H, d, J = 4.0
Hz), 5.45 (1H, d, J = 13.5 Hz), 3.94 (2H, s), 3.90 (1H, d, J = 13.5 Hz),
2.70−2.89 (2H, m), 2.32−2.47 (1H, m), 2.14−2.24 (1H, m), 1.28
(3H, s); 13C NMR δC (CDCl3, 75 MHz) 166.9, 138.3, 136.4, 136.2,
131.3, 130.5, 128.4, 128.0, 127.9, 127.8, 127.2, 122.0, 121.8, 50.8, 42.4,
29.6, 27.4, 19.2; MS m/z (ESI) 348 ([M]+Na) [found ([M]+H)
326.1313, C20H21ClNO requires 326.1306]; HPLC (S,S)-Whelk-O1




chloroacetamide (13b) (540 mg, 1.66 mmol, 1 equiv) in acetone (35
mL) was cooled to 0 °C and lithium bromide (1.43 g, 16.6 mmol, 10
equiv) added. The resulting mixture was stirred at room temperature
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for 60 h. The reaction mixture was concentrated in vacuo to give a
white solid which was taken up in water (30 mL) and extracted with
DCM (3 × 20 mL). The combined organic extracts were then washed
with cold water (30 mL), dried over MgSO4, filtered, and concentrated
in vacuo. The crude product was then purified by recyrstallization from
hexane to give an orange crystalline solid. Yield 519 mg (84%); mp
94−96 °C; Rf 0.19 (pet. ether:EtOAc, 9:1); IR υmax (film)/cm−1 2926,
1660; 1H NMR δH (CDCl3, 300 MHz) 7.09−7.29 (8H, m), 6.94 (1H,
dt, J = 7.5, 2.0 Hz), 5.40 (1H, d, J = 13.5 Hz), 3.92 (1H, d, J = 13.5
Hz), 3.77 (2H, s), 2.72−2.84 (2H, m), 2.47−2.28 (1H, m), 2.26−2.11
(1H, m), 1.28 (3H, s); 13C NMR δC (CDCl3, 100 MHz) 166.3, 138.2,
136.4, 136.2, 131.4, 131.1, 130.4, 128.4, 127.9, 127.7, 127.1, 122.0,
50.9, 29.7, 28.1, 27.4, 19.5; MS m/z (ESI) found ([M]+Na) 392.0626,
C20H20BrNNaO requires 392.0620; HPLC (S,S)-Whelk-O1 (25 cm ×
4.6 mm) hexanes:iPrOH (1.0 mL/min) tR 28.64 and 35.10 min.
Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-iodoaceta-
mide (27d). N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
chloroacetamide (27b) (209 mg, 0.62 mmol, 1 equiv) in acetone
(35 mL) was cooled to 0 °C and lithium iodide (830 mg, 6.20 mmol,
10 equiv) added. The resulting mixture was stirred at room
temperature for 36 h. The reaction mixture was concentrated in
vacuo to give a white solid which was taken up in water (30 mL) and
extracted with EtOAc (3 × 20 mL). The combined organic extracts
were then washed with Na2S2O3 (100 mL) and brine (100 mL), dried
over MgSO4, filtered, and concentrated in vacuo. The crude product
was then purified by recyrstallization from hexane to give an orange
crystalline solid. Yield 191 mg (74%); Rf 0.60 (pet. ether:EtOAc, 3:1);
IR υmax (film)/cm
−1 2929, 1652; 1H NMR δH (CDCl3, 300 MHz)
7.31−7.18 (8H, m), 6.95−6.97 (1H, m), 5.36 (1H, d, J = 14.1 Hz),
3.4.0 (1H, d, J = 14.1 Hz), 3.74 (1H, d, J = 12.1 Hz), 3.71 (1H, d, J =
12.1 Hz), 2.83−2.77 (2H, m), 2.50−2.40 (1H, m), 2.25−2.18 (1H,
m), 1.36 (3H, s); 13C NMR δC (CDCl3, 100 MHz) 168.5, 138.0 136.7,
136.4, 131.9, 131.7, 130.6, 128.5, 128.1, 127.9, 127.2, 122.5, 51.3, 31.2,
29.9, 27.6, 20.1, −1.7; MS m/z (ESI) found ([M]+Na) 440.0482,
C20H20INNaO requires 440.0487.
N-Benzyl-2-chloro-N-(2,6,6-trimethylcyclohex-1-enyl)acetamide
(28). 2,2,6-Trimethylcyclohexanone oxime87 (750 mg, 4.83 mmol),
chloroacetic acid (1.37 g, 14.5 mmol), chloroacetic anhydride (2.48 g,
14.5 mmol), and iron powder (0.54 g, 9.65 mmol) in anhydrous
toluene (25 mL) were heated to reflux under N2 for 14 h. The mixture
was filtered through Celite, diluted with dichloromethane (25 mL),
and washed with 2 M NaOH (2 × 50 mL) and brine (50 mL). The
organic phases were dried over MgSO4, filtered, and concentrated in
vacuo to give a brown solid (390 mg) which was used without further
purification. To this solid was added sodium hydride (145 mg, 1.81
mmol) in anhydrous THF (18 mL) and the mixture cooled to 0 °C.
Benzyl bromide (0.23 mL, 1.90 mmol) was added and the reaction
heated at reflux for 16 h. Water was added (50 mL) and the crude
mixture extracted with EtOAc (3 × 60 mL). The combined extractes
were dried over MgSO4, filtered, and concentrated in vacuo. The crude
product was purified by column chromatography (pet. ether:EtOAc,
9:1) to give a yellow oil. Yield 250 mg (17%); Rf 0.26 (pet.
ether:EtOAc, 6:1); IR υmax (film)/cm
−1 2932, 1658; 1H NMR δH
(CDCl3, 300 MHz) 7.18−7.39 (5H, m), 5.09 (1H, d, J = 14.0 Hz),
4.31 (1H, d, J = 14.0 Hz), 4.10 (1H, d, J = 13.5 Hz), 3.92 (1H, d, J =
13.5 Hz), 2.02 (2H, t, J = 6.0 Hz), 1.47−1.82 (4H, m), 1.20 (3H, s),
1.04 (3H, s), 1.02 (3H, s); 13C NMR δC (CDCl3, 100 MHz) 167.7,
138.0, 136.9, 135.8, 129.7, 128.4, 127.6, 52.4, 42.0, 41.0, 35.9, 31.8,
30.5, 27.8, 19.5, 18.5; MS m/z (ESI) found ([M]+H) 306.1622,
C18H25ClNNO requires 306.1625.
Cyclization of N-Benzyl-2-chloro-N-(cyclohexylidene(phenyl)-
methyl)acetamide (26a) with Bu3SnH. N-Benzyl-2-chloro-N-
(cyclohexylidene(phenyl)methyl)acetamide (26a) (500 mg, 1.49
mmol), Bu3SnH (0.600 mL, 2.23 mmol), and ACN (72.7 mg, 0.298
mmol) in toluene (75 mL) were heated to reflux for 26 h. The
reaction mixture was then cooled and concentrated in vacuo. The
residue was then partitioned between acetonitrile (50 mL) and hexane
(50 mL), and the acetonitrile phase was concentrated in vacuo to give
the crude product as a brown oil (434 mg). Purification of the crude
mixture (14:1 to 9:1, pet. ether:EtOAC) furnished N-benzyl-N-
(cyclohexylidene(phenyl)methyl)-acetamide (7d) (132 mg, 28%),
recovered starting material N-benzyl-2-chloro-N-(cyclohexylidene-
(phenyl)methyl)acetamide (26a) (105 mg, 21%), and an inseparable
mixture of 2-benzyl-1-phenyl-2-azaspiro[4.5]decan-3-one (37a) (118
mg, 25%) and 2-benzyl-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-
one (37b) (73 mg, 15%).
Discernable data for 37a: 1H NMR δH (CDCl3, 400 MHz) 6.93−
7.45 (10H, m), 5.15 (1H, d, J = 14.5 Hz), 3.92 (1H, s), 3.41 (1H, d, J
= 14.5 Hz), 2.43 (2H, q, J = 17.0 Hz), 0.73−1.79 (10H, m); MS m/z
(ESI) found ([M]+Na) 342.1825, C22H25NNaO requires 342.1834.
Discernable data for 37b: 1H NMR δH (CDCl3, 400 MHz) 6.93−
7.45 (10H, m), 4.88 (1H, d, J = 15.0 Hz), 3.90 (1H, d, J = 15.0 Hz),
2.95 (1H, br s), 2.61 (1H, d, J = 17.0 Hz), 2.35 (1H, d, J = 17.0 Hz),
0.73−1.79 (10H, m); MS m/z (ESI) found ([M]+Na) 358.1778,
C22H25NNaO2 requires 358.1783.
Data for mixture: IR υmax (film)/cm
−1 3325, 2924, 2854, 1664; 13C
NMR δC (CDCl3, 100 MHz) 175.1, 138.9, 128.8, 137.0, 136.3, 128.6,
128.5, 128.3, 128.2, 128.1, 127.6, 127.4, 127.3, 98.2, 72.1, 45.8, 44.4,
44.0, 41.0, 40.6, 39.5, 37.8, 34.5, 33.8, 30.2, 25.7, 25.6, 23.1, 23.1, 22.8,
22.5.
Cyclization of N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-
yl)-2-chloroacetamide (27a) with Bu3SnH/Et3B. To a solution of
N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide
(27a) (50 mg, 0.14 mmol) in dry benzene (21 mL) were added
Bu3SnH (63 μL, 0.21 mmol) and Et3B (1.0M, 140 μL, 0.14 mmol),
and the flask was stirred open to the atmosphere for 24 h. Another
aliquot of Bu3SnH (63 μL, 0.21 mmol) and Et3B (1.0 M, 140 μL, 0.14
mmol) was added and the reaction stirred for a further 24 h. The
solvent was evaporated and the crude oil purified by column
chromatography (pet. ether:EtOAc 4:1) to give recovered starting
material 27a (22 mg, 44%) and N-benzyl-N-(2-methyl-3,4-dihydro-
naphthalen-1-yl)acetamide (7b) (19 mg, 70% based upon recovered
starting material).
Cyclisation of N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-
yl)-2-chloroacetamide (27a) with Bu3SnH/AIBN. To a degassed
solution of N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
chloroacetamide (27a) (50 mg, 0.14 mmol) in dry toluene (10 mL)
at reflux was added a degassed mixture of Bu3SnH (58 μL, 0.18 mmol)
and AIBN (5.0 mg, 0.030 mmol) in toluene (10 mL) via a syringe
pump over 2 h. After 48 h the solvent was removed in vacuo and the
residue partitioned between 8% KF (50 mL) and Et2O (20 mL) and
stirred for 4 h. The resulting organic layer was filtered through Celite
and concentrated to yield a crude product which was purified by flash
chromatography (pet. ether:EtOAc 10:1) to give recovered starting
material (24 mg, 48%) and N-benzyl-N-(2-methylnaphthalen-1-yl)-2-
chloroacetamide 38a (11 mg, 42% based upon recovered starting
material); yellow oil; IR υmax (film)/cm
−1 2928, 2857, 1667; 1H NMR
δH (CDCl3, 300 MHz) 7.65 (1H, d, J = 8.5 Hz), 7.58 (1H, d, J = 8.5
Hz) 7.30−7.20 (3H, m), 7.09 (1H, d, J = 8.5 Hz), 6.90−7.05 (5H, m),
5.10 (1H, d, J = 13.5 Hz), 4.37 (1H, d, J = 13.5 Hz), 3.48 (1H, d, J =
14.0 Hz), 3.40 (1H, d, J = 14.0 Hz), 1.72 (3H, s); 13C NMR δC
(CDCl3, 75.5 MHz) 167.0, 136.2, 134.9, 134.1, 133.4, 130.4, 129.2,
128.9, 128.5, 128.4, 128.0, 127.8, 126.1, 122.2, 53.3, 42.5, 18.1; MS m/
z (ESI) found ([M]+Na), 346.0970 C20H 18ClNNaO requires
346.0975.
N-Benzyl-N-(2-methylnaphthalen-1-yl)-2-iodoacetamide (38b).
To a solution of N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-
2-iodoacetamide (27d) (54 mg, 0.13 mmol) in toluene (5 mL) was
added AIBN (21 mg, 0.13 mmol) and the mixture heated at reflux for
2 h. Another equivalent of AIBN was added (21 mg, 0.13 mmol) and
the mixture reacted for a further 24 h. Removal of the solvent in vacuo
followed by purification by column chromatography (pet. ether:-
EtOAc, 5:1) gave a yellow oil (28 mg, 52%). IR υmax (film)/cm
−1 2923,
2851, 1649; 1H NMR δH (CDCl3, 300 MHz) 7.77 (1H, d, J = 8.0 Hz),
7.70 (1H, d, J = 8.0 Hz), 7.45−7.05 (9H, m), 5.14 (1H, d, J = 13.4
Hz), 4.57 (1H, d, J = 13.4 Hz), 3.39 (1H, d, J = 10.7 Hz), 3.35 (1H, d,
J = 10.7 Hz), 1.93 (3H, s); 13C NMR δC (CDCl3, 75.5 MHz) 168.5,
136.3, 135.4, 134.7, 133.4, 130.4, 130.4, 129.1, 129.0, 128.5, 128.4,
128.0, 127.5, 126.0, 122.8, 53.5, 18.6, −1.7; MS m/z (ESI) found
([M]+Na) 438.0325, C20H18INNaO requires 438.0331.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.6b00889
J. Org. Chem. 2016, 81, 5547−5565
5561
Cyclization of N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-
yl)-2-bromoacetamide (27b) with Bu3SnH. To a degassed solution
of N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-bromooaceta-
mide (27b) (150 mg, 0.405 mmol) in dry toluene (20 mL) at reflux
were added Bu3SnH (163 μL, 0.608 mmol) and ACN (20 mg, 0.08
mmol). After 24 h a further aliquot of Bu3SnH (163 μL, 0.608 mmol)
and ACN (20 mg, 0.08 mmol) in toluene (20 mL) was added. For the
next 6 h at 2 h intervals, further ACN was added (3 × 20 mg). After 24
h the reaction mixture was cooled and concentrated in vacuo. The
mixture was portioned between acetonitrile and hexane, and the
acetonitrile phase was concentrated to give a crude yellow oil which
was further purified by column chromatography (pet. ether:EtOAc
9:1), to give N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-
acetamide (7b) (42%), 1-(benzylamino)-1-oxoethan-2-yl 2-(3-
oxobutyl)benzoate (39a), and N-benzyl-N-(2-methylnaphthalen-1-
yl)acetamide (38c).
Data for 39a: yield 14 mg (10%); yellow oil; Rf 0.23 (pet.
ether:EtOAc, 3:1); IR υmax (film)/cm
−1 3067, 1730, 1707, 1664; 1H
NMR δH (CDCl3, 300 MHz) 7.86 (1H, d, J = 8.3 Hz), 7.45 (1H, dt, J
= 7.2, 1.5 Hz), 7.36−7.24 (7H, m), 6.84 (1H, br s), 4.90 (2H, s), 4.56
(2H, d, J = 6.0 Hz), 3.20 (2H, t, J = 7.3 Hz), 2.78 (2H, t, J = 7.3 Hz),
2.06 (3H, s); 13C NMR δC (CDCl3, 75.5 MHz) 208.2, 167.3, 166.1,
143.4, 137.9, 132.7, 131.2, 130.5, 128.8, 128.7, 127.7, 127.6, 126.5,
63.5, 44.9, 43.1, 29.9, 28.0; MS m/z (ESI) found ([M]+Na) 362.1363,
C20H21NNaO4 requires 362.1368.
Data for 38c: yield (7%); yellow oil; IR υmax (film)/cm
−1 3029,
2923, 2854, 1652; 1H NMR δH (CDCl3, 300 MHz) 7.83−7.79 (2H,
m), 7.71 (1H, d, J = 8.5 Hz) 7.57−7.53 (1H, m), 7.37−7.45 (2H, m),
7.25 (1H, d, J = 8.5 Hz), 7.20−7.05 (4H, m), 5.35 (1H, d, J = 13.5
Hz), 4.43 (1H, d, J = 13.5 Hz), 1.87 (3H, s), 1.68 (3H, s); 13C NMR
δC (CDCl3, 75.5 MHz) 171.3, 137.0, 136.1, 124.4, 1233.3, 120.4,
120.2, 128.8, 128.3, 128.2, 127.6, 127.2, 125.7, 122.5, 52.1, 21.9, 17.9;
MS m/z (ESI) found ([M]+Na), 312.1357 C20H19NNaO requires]
312.1359.
General Procedure for Cyclization Using Cu(TPMA)X.
Enamide (1 equiv), either CuCl (1 equiv) or CuBr (0.6−1.2 equiv),
and TPA (0.6−1.2 equiv) were heated to reflux in toluene (0.12 M)
for 2−44 h. The reaction mixture was then cooled to room
temperature and filtered through a silica plug with EtOAc. The filtrate
was then concentrated in vacuo to give the crude products, which were
purified by column chromatography.
1-Benzyl-3,3-dichloro-3a-phenyl-3a,4,5,6-tetrahydro-1H-indol-
2(3H)-one (41). Conditions: N-benzyl-2,2,2-trichloro-N-(2-phenyl-
cyclohex-1-enyl)acetamide (24a) (200 mg, 0.49 mmol), CuCl (48.5
mg, 0.49 mmol), TPA (142 mg, 0.49 mmol), and toluene (4.2 mL),
for 2 h. The crude product was purified by column chromatography
(pet. ether:EtOAc, 9:1). Yield 123 mg (70%); colorless oil; Rf 0.37
(pet. ether:EtOAc, 9:1); IR υmax (film)/cm
−1 2956, 2875, 1730, 1685;
1H NMR δH (CDCl3, 400 MHz) 7.24−7.43 (5H, m), 7.10−7.15 (3H,
m), 7.06−7.10 (2H, m), 5.33 (1H, t, J = 3.5 Hz), 4.95 (1H, d, J = 15.0
Hz), 4.78 (1H, d, J = 15.0 Hz), 2.50−2.54 (2H, m), 1.98−2.13 (3H,
m), 1.70−1.75 (1H, m), 1.05−1.17 (1H, m); 13C NMR δC (CDCl3,
100 MHz) δ 166.3, 139.1, 138.2, 135.1, 129.0, 128.8, 128.1, 128.1,
128.1, 127.8, 105.4, 89.1, 56.8, 45.2, 29.3, 23.1, 18.1; MS m/z (ESI)
found ([M]+Na) 394.0732, C21H19Cl2NNaO requires 394.0736.
Cyclization of N-Benzyl-2,2,2-trichloro-N-(2-methyl-1-phenyl-
prop-1-enyl)acetamide (25b) with Cu(TPMA)Cl. Conditions: N-
benzyl-2,2,2-trichloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide
(25b) (150 mg, 0.39 mmol), CuCl (38.8 mg, 0.39 mmol), TPA (114
mg, 0.39 mmol), and toluene (3.5 mL). The crude product was
purified by column chromatography (pet. ether:EtOAc, 10:1) to give
1-benzyl-3-chloro-5-hydroxy-4,4-dimethyl-5-phenylpyrrolidin-2-one
(42a) (68 mg, 48%) and 1-benzyl-3-chloro-5-hydroxy-4,4-dimethyl-5-
phenylpyrrolidin-2-one (42b) (17 mg, 13%) as colorless solids.
Data for 42a: Rf 0.18 (pet. ether:EtOAc, 6:1); mp 171−172 °C; IR
υmax (film)/cm
−1 3520, 1676; 1H NMR δH (CDCl3, 400 MHz) 7.31−
7.55 (4H, br m), 7.16−7.31 (6H, br m), 4.97 (1H, d, J = 15.0 Hz),
4.23 (1H, d, J = 15.0 Hz), 2.89 (1H, s), 1.35 (3H, s), 0.88 (3H, s); 13C
NMR δC (CDCl3, 100 MHz) 167.8, 136.9, 136.6, 129.2, 129.1, 128.7,
128.1, 128.0, 128.0, 96.0, 90.8, 52.7, 46.2, 26.7, 18.2; MS m/z (ESI)
found ([M]+Na) 386.0691, C19H19Cl2NNaO2 requires 386.0691.
Data for 42b: Rf 0.10 (pet. ether:EtOAc, 6:1); mp 183−185 °C; IR
υmax (film)/cm
−1 3376, 1677; 1H NMR δH (CDCl3, 400 MHz) 7.37−
7.48 (3H, m), 7.29−7.37 (2H, m), 7.17−7.28 (3H, m), 6.96−7.04
(2H, m), 5.16 (1H, d, J = 14.5 Hz), 4.73 (1H, s), 4.13 (1H, d, J = 14.5
Hz), 2.08 (1H, s), 1.10 (3H, s), 0.77 (3H, s); 13C NMR δC (CDCl3,
100 MHz) 172.2, 137.3 136.8 129.3, 129.1, 128.8, 128.34, 128.2, 96.0,
65.9, 48.4, 44.7, 22.1, 19.3); MS m/z (ESI) found ([M]+H) 330.1255,
C19H21ClNO2 requires 330.1261.
Cyclization of N-Benzyl-2,2,2-trichloro-N-(cyclohexylidene-
(phenyl)methyl)-2-methylacetamide (26b) with Cu(TPMA)Cl. Con-
ditions: N-benzyl-2,2,2-trichloro-N-(cyclohexylidene(phenyl)methyl)-
acetamide (26b) (150 mg, 0.355 mmol), CuCl (35.1 mg, 0.355
mmol), TPA (103 mg, 0.355 mmol), and toluene (3.3 mL). The crude
product was purified by column chromatography (pet. ether:EtOAc,
10:1) to give 2-benzyl-4,4-dichloro-1-hydroxy-1-phenyl-2-
azaspiro[4.5]decan-3-one (43a) (33 mg, 23%) and 2-benzyl-4-
chloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one (43b) (21
mg, 16%) as colorless solids.
Data for 43a: Rf 0.21 (pet. ether:EtOAc, 6:1); mp 178−180 °C; IR
υmax (film)/cm
−1 3517, 1728; 1H NMR δH (CDCl3, 400 MHz) 6.86−
7.86 (10H, m), 4.82 (1H, d, J = 15.0 Hz), 4.03 (1H, d, J = 15.0 Hz),
2.80 (1H, br s), 1.94−2.09 (1H, m), 1.72−1.87 (1H, m), 1.41−1.70
(4H, m), 1.23−1.41 (1H, m), 1.10−1.23 (1H, m), 0.91−1.10 (1H, m),
0.54−0.76 (1H, m); 13C NMR δC (CDCl3, 100 MHz) 167.9, 137.3,
136.9, 129.2, 129.1, 128.7, 127.9, 96.7, 92.0, 53.7, 46.3, 32.8, 28.7, 24.9,
22.2, 21.8; MS m/z (ESI) found ([M]+Na) 426.0998,
C22H23Cl2NNaO2 requires 426.1004.
Data for 43b: Rf 0.18 (pet. ether:EtOAc, 6:1); mp 183−185 °C; IR
υmax (film)/cm
−1 3213, 1687; 1H NMR δH (CDCl3, 400 MHz) 6.76−
7.81 (10H, m), 4.84 (1H, d, J = 15.0 Hz), 4.47 (1H, s), 4.19 (1H, d, J
= 15.0 Hz), 2.58 (1H, s), 2.26 (1H, dd, J = 13.5, 2.5 Hz), 1.48−1.77
(3H, m), 1.13−1.42 (4H, m), 0.79−0.96 (1H, m), 0.69 (1H, td, J =
13.0, 4.0 Hz); 13C NMR δC (CDCl3, 100 MHz) 172.4, 137.6, 136.2,
128.9, 128.8, 128.7, 128.3, 127.7, 98.6, 60.5, 48.3, 45.3, 33.8, 26.6, 24.8,
22.8, 22.5; MS m/z (ESI) found ([M]+Na) 392.1388,
C22H24ClNNaO2 requires 392.1393.
Cyclization of N-Benzyl-2-bromo-2-methyl-N-(2-methyl-1-phe-
nylprop-1-enyl)propanamide (25c) with Cu(TPMA]Br. Conditions:
N-benzyl-2-bromo-2-methyl-N-(2-methyl-1-phenylprop-1-enyl)-
propanamide (25c) (200 mg, 0.518 mmol), CuBr (44.6 mg, 0.311
mmol), TPA (90.2 mg, 0.311 mmol), and toluene (5 mL). The crude
product was purified by column chromatography (6:1, pet. ether-
EtOAc) to yield 1-benzyl-5-hydroxy-3,3,4,4-tetramethyl-5-phenylpyr-
rolidin-2-one (44) as a white solid (61 mg, 36%) and a 4:1 inseparable
mixture of 1-benzyl-3,3,4,4-tetramethyl-5-phenylpyrrolidin-2-one (45)
and 2-benzyl-4,4,5-trimethyl-1-phenyl-2-azabicyclo[3.1.0]hexan-3-one
(46) (19%, 45:46 = 5:1).
Data for 44: Rf 0.16 (pet. ether:EtOAc, 6:1); mp 117−119 °C; IR
υmax (film)/cm
−1 3221, 1666; 1H NMR δH (CDCl3, 400 MHz) 7.14−
7.48 (8H, m), 7.01−7.14 (2H, m), 5.20 (1H, d, J = 15.0 Hz), 4.03
(1H, d, J = 15.0 Hz), 1.95 (1H, s), 1.35 (3H, s), 1.09 (3H, s), 0.95
(3H, s), 0.53 (3H, s); 13C NMR δC (CDCl3, 100 MHz) 182.2, 139.3,
138.6, 129.0, 128.6, 128.5, 128.2, 127.9, 97.0, 46.9, 46.1, 44.1, 25.6,
25.0, 20.6, 17.1; MS m/z (ESI) found ([M]+Na) 346.1781,
C21H25NNaO2 requires 346.1783.
Data for 46: inseparable mixture; Rf 0.19 (pet. ether:EtOAc, 6:1);
IR υmax (film)/cm
−1 2972, 2940, 1690; 1H NMR δH (CDCl3, 400
MHz) 6.87−7.44 (10H 45 and 10H 46, m), 5.24 (1H 45, d, J = 14.0
Hz), 4.83 (1H 46, d, J = 14.0 Hz), 3.97 (1H 45, s), 3.72 (1H 46, d, J =
14.0 Hz), 3.66 (1H 45, d, J = 14.0 Hz), 1.32 (3H 46, s), 1.18 (3H 46,
s), 1.08 (3H 45, s), 1.00 (1H 46, d, J = 6.0 Hz), 0.96 (3H 45, s), 0.85
(3H 45, s), 0.79 (3H 46, s), 0.59 (3H 45, s), 0.30 (1H 46, d, J = 6.0
Hz); 13C NMR δC (CDCl3, 150 MHz) mixture 181.2, 179.5, 137.1,
136.3, 135.4, 134.2, 129.5, 129.2, 128.9, 128.5, 128.4, 128.2, 128.1,
127.8, 127.8, 127.5, 127.3, 68.6, 51.6, 46.7, 45.3, 45.3, 44.8, 42.4, 28.8,
25.0, 24.2, 21.6, 21.3, 21.1, 20.7, 19.2, 14.1; MS m/z (ESI) found
([M]+Na) 330.1832, C21H25NNaO requires 330.1834.
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Cyclization of N-Benzyl-2-bromo-N-(cyclohexylidene(phenyl)-
methyl)-2-methylpropanamide (26c) with Cu(TPMA]Br. Conditions:
N-benzyl-2-bromo-N-(cyclohexylidene(phenyl)methyl)-2-methylpro-
panamide (26c) (200 mg, 0.469 mmol), CuBr (40.1 mg, 0.281 mmol),
TPA (81.7 mg, 0.281 mmol), and toluene (5 mL). The crude product
was purified by column chromatography (9:1:0.2, hexane:diethyl
ether:triethylamine), yielding 2-benzyl-1-hydroxy-4,4-dimethyl-1-phe-
nyl-2-azaspiro[4.5]decan-3-one (50) as a white solid (56 mg, 33%)
and an inseparable mixture of 2-benzyl-4,4-dimethyl-1-phenyl-2-
azaspiro[4.5]decan-3-one (52 and 51) (41 mg, 26%, 1:4 = 50:51).
Data for 50: Rf 0.18 (pet. ether:EtOAc, 6:1); mp 169−170 °C; IR
υmax (film)/cm
−1 3165, 1664; 1H NMR δH (CDCl3, 400 MHz) 7.30−
7.66 (4H, m), 7.06−7.30 (4H, m), 6.98−7.05 (2H, m), 5.14 (1H, d, J
= 15.0 Hz), 3.91 (1H, d, J = 15.0 Hz), 1.93 (1H, s), 1.78 (1H, dd, J =
13.5, 6.0 Hz), 1.47−1.58 (2H, m), 1.39 (3H, s), 1.24−1.45 (4H, m),
1.31 (3H, s), 0.97−1.07 (1H, m), 0.87−0.97 (1H, m), 0.77−0.87 (1H,
m); 13C NMR δC (CDCl3, 100 MHz) 182.1, 140.0, 138.4, 128.9,
128.5, 128.4, 127.8, 97.3, 48.7, 47.1, 44.2, 32.4, 30.5, 27.5, 25.5, 25.2,
23.5, 22.7; MS m/z (ESI) found ([M]+Na) 386.2096, C24H29NNaO2
requires 386.2096.
Data for 52 and 51: Rf 0.21 (pet. ether:EtOAc, 6:1); IR υmax (film)/
cm−1 2933, 2866, 1676; 1H NMR δH (CDCl3, 400 MHz) 7.16−7.39
(8H 52, 51, m), 7.02−7.06 (2H 51, m), 6.99−7.02 (2H 52, m), 5.22
(1H 52, d, J = 14.5 Hz), 4.61 (1H 51, d, J = 14.5 Hz), 4.08 (1H 52, s),
3.74 (1H 51, d, J = 14.5 Hz), 3.46 (1H 52, d, J = 14.5 Hz), 1.83−1.93
(1H 52, 51, m), 1.78 (1H 51, td, J = 14.5, 6.5 Hz), 1.57−1.70 (2H 51,
52, m), 1.46−1.54 (2H 52, m), 1.39 (3H 51, s), 1.34−1.41 (3H 52,
m), 1.15−1.30 (3H 52, m), 1.27 (3H 52, s), 1.23 (3H 51, s), 1.11 (3H
51, s), 1.04−1.15 (1H 52, 51, m), 0.95−1.04 (1H 51, m), 0.85 (1H
51, dd, J = 8.5, 2.5 Hz), 0.74−0.82 (1H 51, m), 0.57−0.69 (1H 51,
m); 13C NMR δC (CDCl3, 100 MHz) 180.1, 178.8, 137.7, 136.7,
136.3, 132.7, 132.3, 128.7, 128.6, 128.4, 128.2, 128.2, 128.0, 127.9,
127.5, 126.9, 68.5, 52.6, 47.6, 46.5, 44.9, 44.8, 44.7, 34.0, 31.1, 29.7,
28.4, 25.6, 23.9, 23.8, 23.0, 22.5, 21.8, 21.6, 21.2, 21.2, 20.1; MS m/z
(ESI) found ([M]+H) 348.2323, C24H30NO requires 348.2327.
Cyclization of N-Benzyl-2-bromo-2-methyl-N-(2-methyl-3,4-dihy-
dronaphthalen-1-yl)propanamide (27c) with Cu[TPMA]Br. Con-
ditions: N-benzyl-2-bromo-2-methyl-N-(2-methyl-3,4-dihydronaphtha-
len-1-yl)propanamide (27c) (132 mg, 0.331 mmol), CuBr (28.5 mg,
0.199 mmol), TPA (57.7 mg, 0.199 mmol), and toluene (3.3 mL).
The crude product was purified by column chromatography (10:1 to
5:1, pet. ether:EtOAc) to give 1-benzyl-3,3,3a-trimethyl-3,3a,4,5-
tetrahydro-1H-benzoindol-2(9bH)-one (54) (33 mg, 31%), 1-benzyl-
9b-hydroxy-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2-
(9bH)-one (53) (21 mg, 19%), and 1-benzyl-[3,9b]cyclopropyl-3,3,3a-
trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2(9bH)-one (55) (7 mg,
7%), and 39b (<2%).
Data for 54: Rf 0.15 (pet. ether:EtOAc, 8:1); IR υmax (film)/cm
−1
2925, 2855, 1670; 1H NMR δH (CDCl3, 600 MHz) 7.30 (2H, t, J = 7.5
Hz), 7.21−7.28 (2H, m), 7.15 (1H, d, J = 7.5 Hz), 7.12 (1H, t, J = 7.5
Hz), 7.09 (2H, d, J = 7.5 Hz), 6.92 (1H, d, J = 7.5 Hz), 4.95 (1H, d, J
= 15.5 Hz), 4.24 (1H, s), 3.62 (1H, d, J = 15.5 Hz), 2.79 (2H, dt, J =
12.0, 6.0 Hz), 1.68−1.75 (1H, m), 1.54 (1H, m), 1.24 (3H, s), 1.13
(3H, s), 0.94 (3H, s); 13C NMR δC (CDCl3, 150 MHz) 180.0, 137.8,
137.4, 132.9, 130.1, 129.3, 128.7, 128.6, 127.5, 127.1, 125.5, 61.6, 47.2,
43.3, 41.2, 27.4, 25.9, 20.9, 17.4, 14.8; MS m/z (ESI) found ([M]+Na)
342.1828, C22H25NNaO requires 342.1834.
Data for 53: Rf 0.05 (pet. ether:EtOAc, 8:1);
1H NMR δH (CDCl3,
400 MHz) 7.21−7.29 (1H, m), 6.59−6.91 (8H, m), 4.30 (1H, d, J =
15.5 Hz), 3.80 (1H, d, J = 15.5 Hz), 2.47 (1H, ddd, J = 17.5, 11.0, 6.5
Hz), 2.27 (1H, dt, J = 17.5, 4.5 Hz), 1.95 (1H, s), 1.17−1.48 (2H, m),
1.14 (3H, s), 0.77 (3H, s), 0.72 (3H, s); 13C NMR δC (CDCl3, 100
MHz) 181.4, 138.6, 136.8, 135.3, 128.9, 128.8, 128.3, 127.5, 126.8,
126.3, 91.6, 46.2, 45.3, 43.2, 31.6, 25.8, 25.5, 19.5, 13.0; MS m/z (ESI)
found ([M]+Na) 358.1778, C22H25NNaO2 requires 358.1738.
Data for 55: Rf 0.26 (pet. ether:EtOAc, 8:1);
1H NMR δH (CDCl3,
600 MHz) 7.08−7.54 (7H, m), 7.00−7.07 (2H, m), 4.92 (1H, d, J =
14.5 Hz), 4.30 (1H, d, J = 14.5 Hz), 2.89 (1H, dd, J = 17.5, 7.5 Hz),
2.54 (1H, d, J = 17.5 Hz), 1.33 (3H, s), 1.13 (3H, s), 0.90 (1H, d, J =
7.5 Hz), 0.64 (3H, s); 13C NMR δC (CDCl3, 150 MHz) 180.3, 143.3,
137.5, 137.1, 128.9, 128.4, 127.5, 126.8, 126.5, 125.0, 123.6, 59.6, 52.9,
45.8, 44.5, 32.6, 30.9, 25.2, 21.4, 6.6; MS m/z (ESI) found ([M]+H)
318.1860, C22H24NO requires 318.1858.
Data for 39b: Rf 0.14 (pet. ether:EtOAc, 6:1);
1H NMR δH (600
MHz, CDCl3) 7.76 (1H, dd, J 8.0, 1.5 Hz), 7.40 (1H, td, J = 7.5, 1.5
Hz), 7.27−7.34 (4H, m), 7.21−7.27 (3H, m), 6.64 (1H, br t, J = 7.5
Hz), 4.50 (2H, d, J = 7.5 Hz), 3.10 (2H, t, J = 7.5 Hz), 2.73 (2H, t, J =
7.5 Hz), 2.04 (3H, s), 1.77 (6H, s); 13C NMR δC (150 MHz, CDCl3)
208.3, 173.0, 166.2, 142.9, 138.4, 132.3, 131.1, 130.4, 128.7, 127.8,
127.5, 126.3, 81.7, 45.2, 43.6, 30.0, 28.0, 25.0; MS m/z (ESI) found
([M]+H) 368.1856, C22H26NO4 requires 368.1862.
Data for mixture: HPLC (S,S)-Whelk-O1 (25 cm × 4.6 mm)
hexanes:iPrOH (1.0 mL/min) 53, tR 18.88 and 31.03 min; 39b, tR
111.01 min; 54, tR 14.77 and 52.03 min; 55, tR 9.87 and 11.55 min.
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